Other sleep disorders

G6_SLEEPDISOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G47 Hospital discharge: ICD-9 — 3478\|3074 Hospital discharge: excluded ICD-10 — G47.3, G47.4 Cause of death: ICD-10 — G47 Cause of death: ICD-9 — 3478\|3074 Cause of death: excluded ICD-10 — G47.3, G47.4 2 out of 7 registries used, show all original rules.	5155
4. Check minimum number of events None	5155
5. Include endpoints None	5155
6. Filter based on genotype QC (FinnGen only)	4959

Control definitions (FinnGen only)

Control exclude: G6_EPIPAROX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G40-G47
Name in latin: Perturbationes somni (organicae)

NAME	G6_SLEEPDISOTH
CONTROL_EXCLUDE	G6_EPIPAROX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G47
HD_ICD_9	3478\|3074
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	G47[3-4]
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G47
COD_ICD_9	3478\|3074
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	G47[3-4]
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other sleep disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37822	14792	22784
Only index persons	33930	13696	20234
Unadjusted period prevalence (%)
Whole population	0.55	0.42	0.64
Only index persons	0.66	0.50	0.77
Median age at first event (years)
Whole population	48.61	48.62	48.49
Only index persons	47.84	48.07	47.68

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4959	2447	2512
Unadjusted period prevalence (%)	1.01	0.87	1.15
Median age at first event (years)	49.83	47.98	51.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5154: Matched controls
51539

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G44.2

ICD-10 Finland

Tension-type headache

5.0

323.0

780

1780

N06AX16

ATC

venlafaxine; oral

4.0

317.8

1088

3243

N05AH04

ATC

quetiapine; oral

3.9

307.7

1466

4717

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

32.1

307.7

986

377

XG466

NOMESCO Finland

Sleep oxymetry

24.9

307.7

388

168

P06

ICPC

Sleep disturbance

4.8

307.7

918

2233

G47.9

ICD-10 Finland

Sleep disorder, unspecified

192.4

307.7

2520

255

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

26.3

307.7

300

121

WX722

NOMESCO Finland

PEEP

19.1

307.7

480

276

R5140

NOMESCO Finland

Monitoring the use of the aid

20.1

307.7

934

562

WX780

NOMESCO Finland

Remote monitoring CPAP

3181.2

307.7

310

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.8

307.7

873

1305

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

397.4

307.7

369

G47.3

ICD-10 Finland

Sleep apnoea

66.3

307.7

2697

839

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

4562.9

307.7

430

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

584

R06.5

ICD-10 Finland

Mouth breathing

9.4

307.7

940

1196

WX723

NOMESCO Finland

CPAP therapy

264.4

307.7

299

G47.8

ICD-10 Finland

Other sleep disorders

24.6

307.7

491

220

N06AX11

ATC

mirtazapine; oral

3.6

307.7

2418

10157

G40.9

ICD-10 Finland

Epilepsy, unspecified

88.2

292.9

154

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.7

265.3

988

3093

N06AB04

ATC

citalopram; systemic

3.2

262.6

1368

5278

N06AX21

ATC

duloxetine; oral

4.0

262.1

840

2369

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

261.4

1199

4286

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

7.8

255.4

368

505

G43.9

ICD-10 Finland

Migraine, unspecified

8.7

254.5

331

402

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

254.3

242

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

239.8

623

1495

N03AE01

ATC

clonazepam; systemic

5.4

238.2

498

995

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

237.3

226

R53

ICD-10 Finland

Malaise and fatigue

2.9

235.5

1509

6485

N03AG01

ATC

valproic acid; systemic, rectal

6.1

232.4

423

742

N05CF01

ATC

zopiclone; oral

2.7

231.7

1937

9522

Z01.8

ICD-10 Finland

Other specified special examinations

2.9

226.3

1426

6057

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

222.5

212

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

8.2

221.3

303

391

R51.80

ICD-10 Finland

Headache

3.4

220.1

927

3117

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.9

219.8

734

2118

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

7.7

219.6

318

438

XA420

NOMESCO Finland

Extensive sleep examination

44.9

214.7

127

N05BA04

ATC

oxazepam; oral

2.7

207.7

1568

7262

N03AX09

ATC

lamotrigine; oral

5.8

207.2

395

723

N03AX16

ATC

[U] pregabalin

2.8

206.5

1392

6087

E66.01

ICD-10 Finland

Obesity due to excess calories

4.3

205.9

581

1481

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

3.7

203.4

728

2197

N04BC05

ATC

pramipexole; oral

4.3

200.0

567

1449

N06BA07

ATC

modafinil; oral

51.1

200.0

115

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

197.4

533

1312

N06AB03

ATC

fluoxetine; oral

3.3

195.9

842

2854

N06AB10

ATC

escitalopram; oral

2.7

192.0

1285

5573

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.3

188.8

397

794

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.8

186.0

625

1802

N06AX12

ATC

bupropion; oral

4.1

184.4

552

1466

E66.8

ICD-10 Finland

Other obesity

5.3

180.1

384

777

R06.0

ICD-10 Finland

Dyspnoea

2.5

178.4

1480

7096

N03AF02

ATC

oxcarbazepine; oral

11.8

175.5

181

159

N06AX03

ATC

mianserin; oral

5.0

172.3

394

846

E66.00

ICD-10 Finland

Metabolic syndrome

4.9

171.3

395

854

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.6

170.1

434

1019

N03AX12

ATC

[U] gabapentin; oral

2.9

167.8

959

3804

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.6

166.1

611

1867

N05BA01

ATC

diazepam; systemic, rectal

3.1

165.2

809

2945

N03AX11

ATC

topiramate; oral

11.9

162.2

166

144

R03AC02

ATC

salbutamol; inhalant

2.2

161.7

2926

19272

N06AB06

ATC

sertraline; oral

3.1

160.1

756

2692

N02AX02

ATC

tramadol; systemic, rectal

2.2

159.3

2302

13854

G43.3

ICD-10 Finland

Complicated migraine

33.2

157.8

101

N06AX26

ATC

vortioxetine; oral

3.8

156.9

529

1523

N06AA09

ATC

amitriptyline; systemic

3.6

156.5

570

1728

N05CF02

ATC

zolpidem; oral

2.6

155.7

1063

4606

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

154.3

1071

4677

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.0

147.3

229

340

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

145.9

731

2685

N06AA12

ATC

doxepin; systemic

4.5

145.7

376

889

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

144.7

524

1580

ENC30

NOMESCO Finland

Plastic operation of pharynx

13.0

143.8

139

110

N05CD07

ATC

temazepam; oral

3.0

143.7

699

2523

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.7

140.1

341

769

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

186.4

139.3

145

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

137.7

1546

8309

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

136.9

1476

7800

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.3

135.0

563

1853

R42

ICD-10 Finland

Dizziness and giddiness

2.4

133.9

1153

5529

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.9

131.8

689

2583

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

131.7

1951

11633

M54.5

ICD-10 Finland

Low back pain

2.1

130.9

1906

11287

M79.7

ICD-10 Finland

Fibromyalgia

5.8

129.3

242

433

G45.3

ICD-10 Finland

Amaurosis fugax

60.8

129.2

A02BC02

ATC

pantoprazole; systemic

2.1

129.2

3434

25203

E66.9

ICD-10 Finland

Obesity, unspecified

5.5

126.7

250

470

C07AA05

ATC

propranolol; systemic

2.3

126.2

1134

5524

R01AD09

ATC

mometasone; nasal

2.0

125.9

2354

15201

N05AH03

ATC

olanzapine; systemic

3.5

124.1

457

1389

N06AX05

ATC

trazodone; oral

5.9

123.7

226

395

A02BC05

ATC

esomeprazole; systemic

2.0

123.7

2076

12882

AA1AD

NOMESCO Finland

CT of head and brain

2.3

123.6

1228

6236

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

122.0

406

1153

N05AA02

ATC

levomepromazine; systemic

4.4

121.9

320

765

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

119.8

1324

7010

4471

FHL

Pharyngoplasty

53.0

118.9

M79.6

ICD-10 Finland

Pain in limb

2.0

116.8

2121

13459

N06BA04

ATC

methylphenidate; oral

4.7

116.7

278

615

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

174.0

113.8

119

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.8

112.1

637

2486

N05BA12

ATC

alprazolam; oral

2.9

111.9

603

2289

A02BC03

ATC

lansoprazole; oral

2.1

111.7

1441

8066

P03

ICPC

Feeling depressed

2.8

111.5

613

2351

N06AG02

ATC

moclobemide; oral

4.2

110.9

306

759

A02BC01

ATC

omeprazole; systemic

2.1

110.1

1409

7857

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

21.3

109.6

P76

ICPC

Depressive disorder

3.4

109.6

429

1353

M79.1

ICD-10 Finland

Myalgia

2.5

109.2

818

3654

3007

Kela drug reimbursment

Erenumab and fremanezumab

31.3

108.9

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

20.1

108.0

SPAT1094

SPAT

Continuous Positive Airway Pressure

60.7

107.6

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.5

106.4

265

607

R04

ICPC

Breathing problem other

4.7

106.3

254

563

N03AF01

ATC

carbamazepine; oral, rectal

4.4

105.9

274

647

F34.1

ICD-10 Finland

Dysthymia

4.5

105.7

264

606

SPAT1377

SPAT

Polysomnography

6.5

105.7

174

274

P29

ICPC

Psychological sympt/compl other

3.1

105.1

472

1616

H02AB06

ATC

prednisolone; systemic

1.9

105.0

2381

16097

N06AA06

ATC

trimipramine; systemic

5.4

104.9

211

403

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

12.9

104.3

101

C03CA01

ATC

furosemide; systemic

2.1

103.9

1382

7790

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.7

103.9

245

537

A02BA02

ATC

ranitidine; systemic

2.3

101.5

973

4827

C07AB07

ATC

bisoprolol; oral

1.9

101.2

2278

15309

K07.60

ICD-10 Finland

Snapping jaw

3.6

100.3

348

1014

N06AB05

ATC

paroxetine; oral

3.4

100.0

381

1180

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

99.4

300

794

N06AX22

ATC

agomelatine; oral

5.8

99.3

185

329

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.3

98.2

201

390

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

98.2

2177

14519

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

97.5

2228

14992

SPAT1240

SPAT

Therapeutic discussion

2.6

97.3

628

2605

M03BX02

ATC

tizanidine; oral

1.9

97.3

3079

22900

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

97.0

927

4585

J34.2

ICD-10 Finland

Deviated nasal septum

3.6

96.7

343

1014

N02BF01

ATC

gabapentin; oral

3.0

96.2

467

1669

R40.0

ICD-10 Finland

Somnolence

23.3

95.5

A04

ICPC

Weakness/tiredness general

2.3

95.1

807

3793

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

94.9

1164

6341

SPAT1051

SPAT

Guidance regarding sleep disorders

8.6

94.5

121

143

N05AX08

ATC

risperidone; systemic

2.9

94.5

484

1781

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.7

94.2

582

2361

N02CD03

ATC

fremanezumab; systemic

43.5

93.8

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

12.7

91.5

SBB10

NOMESCO Finland

Dental impressions

3.0

91.1

427

1495

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

91.1

1781

11349

L03

ICPC

Low back symptom/complaint

2.0

90.7

1389

8169

R03DC03

ATC

montelukast; oral

2.2

90.2

859

4231

J01AA02

ATC

doxycycline; systemic

1.9

90.0

3814

30713

R01AD08

ATC

fluticasone; nasal

1.9

90.0

1462

8767

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

89.5

1143

6301

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

88.8

1004

5290

T82

ICPC

Obesity

4.4

88.4

225

524

R52.9

ICD-10 Finland

Pain, unspecified

2.7

88.1

536

2155

N02BE01

ATC

paracetamol; systemic, rectal

2.3

88.0

4472

38230

DHB50

NOMESCO Finland

Turbinoplasty

5.4

87.9

178

342

G44.0

ICD-10 Finland

Cluster headache syndrome

24.1

87.0

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.3

86.9

231

556

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.0

86.5

257

672

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

7.0

86.3

133

195

TAB00

NOMESCO Finland

Lumbar puncture

3.8

86.2

278

770

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.9

85.8

195

414

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.9

85.7

425

1534

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

85.6

N05AX12

ATC

aripiprazole; systemic

3.7

85.2

278

776

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

85.0

2731

20060

DJD20

NOMESCO Finland

Plastic repair of septum of nose

4.1

84.5

237

594

EB1MA

NOMESCO Finland

Cephalometry with X-ray

5.8

84.5

156

275

M25.5

ICD-10 Finland

Pain in joint

1.9

84.0

1572

9829

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.8

83.9

455

1723

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.3

83.3

172

336

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.6

83.1

161

297

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

82.6

1347

8050

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

811.1

81.7

SPAT1262

SPAT

Handing over of treatment supplies

2.1

81.6

881

4546

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

81.5

891

4619

Z2445

NOMESCO Finland

Psychologist

3.9

81.3

252

679

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.6

81.3

196

437

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.2

80.3

339

1115

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

80.3

311

971

P01

ICPC

Feeling anxious/nervous/tense

2.3

79.9

690

3252

N05BE01

ATC

buspirone; oral

4.4

79.6

207

490

N05AF03

ATC

chlorprothixene; systemic

4.5

79.5

199

457

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

208.3

79.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

79.3

1242

7309

N03AX14

ATC

levetiracetam; systemic

9.2

79.0

106

R03BA05

ATC

fluticasone; inhalant

2.1

79.0

931

4961

F61.0

ICD-10 Finland

Mixed personality disorders

6.1

78.6

139

235

N02CD01

ATC

erenumab; parenteral

35.3

77.8

E66.0

ICD-10 Finland

Obesity due to excess calories

9.7

77.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.9

77.0

393

1439

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.3

76.9

299

935

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.4

76.9

289

885

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

76.0

3620

29305

N06AA04

ATC

clomipramine; systemic

6.2

75.6

131

217

R52.2

ICD-10 Finland

Other chronic pain

3.9

75.4

225

590

J45.1

ICD-10 Finland

Nonallergic asthma

2.8

75.3

393

1456

ZXC60

NOMESCO Finland

Application of heat

6.5

75.3

124

195

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

+∞

74.1

N06AX18

ATC

reboxetine; oral

8.0

74.0

101

129

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

74.0

2055

14304

J31.0

ICD-10 Finland

Chronic rhinitis

2.6

73.8

454

1830

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

73.8

1849

12505

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

73.6

707

3475

SPAT1263

SPAT

Sampling

1.7

73.3

2043

14225

UJF32

NOMESCO Finland

Coloscopy

1.9

72.9

1232

7403

R01AD12

ATC

fluticasone furoate; nasal

1.8

72.9

1532

9842

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

72.6

1137

6667

R99

ICPC

Respiratory disease other

6.6

72.2

117

181

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

130.3

72.1

F45.8

ICD-10 Finland

Other somatoform disorders

2.7

71.6

403

1553

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

71.5

623

2940

A10BA02

ATC

metformin; oral

1.8

71.2

1316

8123

J01DB01

ATC

cefalexin; oral

1.9

70.7

4148

35281

L17

ICPC

Foot/toe symptom/complaint

1.8

70.6

1365

8539

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

70.1

898

4911

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

70.1

473

1992

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

69.6

1985

13853

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

69.6

598

2804

H03AA01

ATC

levothyroxine sodium; systemic

1.9

69.4

1061

6160

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

69.3

263

810

J02AC01

ATC

fluconazole; systemic

1.7

69.2

1806

12300

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

69.0

2079

14716

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

68.9

H53.1

ICD-10 Finland

Subjective visual disturbances

2.9

68.4

336

1204

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

68.3

1479

9550

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

68.0

1079

6337

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

67.9

514

2280

T90

ICPC

Diabetes non-insulin dependent

1.9

67.8

1101

6514

R02

ICPC

Shortness of breath/dyspnoea

2.2

67.7

614

2942

XA421

NOMESCO Finland

Nocturnal polygraphy

31.7

67.6

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.5

67.5

240

709

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.4

67.2

515

2297

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

67.0

1242

7652

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.2

66.4

178

431

R96

ICPC

Asthma

2.4

66.3

479

2080

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.4

66.2

111

178

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

66.1

382

1491

P01AB01

ATC

metronidazole; oral, rectal

1.7

66.0

1871

12990

L28

ICPC

Limited function/disability (L)

2.0

66.0

792

4225

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.0

65.9

191

490

ZY010

NOMESCO Finland

Hospital outpatient

3.0

65.7

312

1097

G43.8

ICD-10 Finland

Other migraine

11.5

65.5

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

65.3

313

1106

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

64.9

232

687

J01DA01

ATC

[U] cefalexin

1.7

64.7

2978

23358

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

64.7

1145

6945

R06AE07

ATC

cetirizine; oral

1.7

64.3

2106

15155

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.2

63.7

173

423

R03BB04

ATC

tiotropium bromide; inhalant

2.4

63.7

488

2175

N02CC06

ATC

eletriptan; oral

4.4

63.6

163

381

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.9

63.6

307

1089

A10BJ02

ATC

liraglutide; parenteral

4.6

63.4

151

333

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

63.1

301

1060

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

63.0

2703

20776

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.4

62.9

125

236

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

62.8

1156

7087

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

62.6

910

5178

160

Kela drug reimbursment

exenatide

5.6

62.3

120

220

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.2

62.2

257

833

C09CA06

ATC

candesartan; oral

1.9

62.2

1038

6174

A06AD11

ATC

lactulose; oral

2.1

62.2

685

3536

G04BD12

ATC

mirabegron; oral

2.2

62.1

555

2640

N01

ICPC

Headache

2.2

61.8

544

2571

K30

ICD-10 Finland

Functional dyspepsia

2.2

61.7

553

2633

N02BF02

ATC

pregabalin; oral

2.9

61.2

306

1106

A01

ICPC

Pain general/multiple sites

2.4

61.1

445

1937

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

61.0

1133

6957

R03BA02

ATC

budesonide; inhalant

1.9

60.9

846

4737

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

60.8

1876

13243

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

60.0

1153

7147

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.9

59.9

108

186

G50.1

ICD-10 Finland

Atypical facial pain

5.6

59.7

115

211

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

59.4

2361

17716

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.7

59.3

194

542

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.7

59.2

138

299

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.6

59.2

142

315

N02CC07

ATC

frovatriptan; oral

3.9

59.0

178

470

J01FA06

ATC

roxithromycin; oral

1.6

58.9

1832

12932

J01MA02

ATC

ciprofloxacin; systemic

1.6

58.9

1829

12906

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

58.6

2542

19454

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

58.4

328

1260

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

6.5

58.2

148

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.5

58.1

403

1715

A03FA02

ATC

cisapride; oral, rectal

2.6

57.6

357

1440

F32

ICD-10 Finland

Depressive episode

2.9

57.5

290

1053

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

57.5

2290

17147

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

57.4

210

631

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

57.2

1396

9237

A28

ICPC

Limited function/disability NOS

2.0

57.2

744

4068

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

57.1

828

4695

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.9

56.9

273

964

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.8

56.9

131

281

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

56.9

3299

26975

M01AH02

ATC

rofecoxib; oral

2.1

56.7

569

2829

K02.1

ICD-10 Finland

Caries of dentine

1.6

56.6

2905

23055

C07AB02

ATC

metoprolol; systemic

1.9

56.6

846

4843

J45.8

ICD-10 Finland

Mixed asthma

3.8

56.5

179

489

R60.0

ICD-10 Finland

Localized oedema

2.2

56.5

556

2744

Z71.8

ICD-10 Finland

Other specified counselling

1.7

56.4

1501

10157

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

56.3

386

1634

R39.1

ICD-10 Finland

Other difficulties with micturition

3.4

56.2

208

630

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

55.9

718

3906

N02CC03

ATC

zolmitriptan; nasal, oral

3.1

55.9

241

801

R11

ICD-10 Finland

Nausea and vomiting

2.4

55.8

424

1880

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

55.7

375

1573

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

55.4

318

1235

R55

ICD-10 Finland

Syncope and collapse

2.2

55.2

505

2420

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

55.1

1236

7982

SFA10

NOMESCO Finland

One-surface restoration

1.6

55.1

2676

20914

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

54.9

384

1640

N05AB03

ATC

perphenazine; systemic, rectal

3.3

54.8

210

650

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

54.7

318

1243

S06.0

ICD-10 Finland

Concussion

2.2

54.5

517

2514

M54.2

ICD-10 Finland

Cervicalgia

2.4

54.4

385

1652

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

54.4

432

1951

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

54.4

1443

9739

J01FF01

ATC

clindamycin; systemic

1.7

54.4

1266

8254

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.1

54.3

556

2785

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

54.0

1154

7345

M01AB05

ATC

diclofenac; systemic, rectal

1.6

53.8

3126

25401

R51

ICD-10 Finland

Headache

2.9

53.6

265

951

R03BA08

ATC

ciclesonide; inhalant

2.3

53.5

415

1855

C08CA01

ATC

amlodipine; oral

1.6

53.3

1630

11392

AA40B, ,

NOMESCO Finland

76.0

53.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

52.8

780

4440

A10BJ06

ATC

semaglutide; parenteral

3.1

52.5

232

782

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

52.4

672

3649

N05AN01

ATC

lithium; oral

3.9

52.3

159

422

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

52.2

207

654

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

52.1

176

502

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.7

52.0

120

258

R01AD58

ATC

fluticasone, combinations; nasal

1.7

51.7

1133

7250

L01

ICPC

Neck symptom/complaint

1.9

51.7

711

3952

Z01.2

ICD-10 Finland

Dental examination

1.6

51.6

2166

16283

N06AB08

ATC

fluvoxamine; oral

3.7

51.6

164

449

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

51.3

673

3681

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.5

51.3

178

517

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.6

51.2

319

1289

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

51.0

600

3160

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

50.9

956

5853

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

50.9

1839

13346

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.6

50.8

120

263

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

50.6

330

1363

R03BA01

ATC

beclometasone; inhalant

2.0

50.6

654

3559

G93.3

ICD-10 Finland

Postviral fatigue syndrome

12.0

50.6

R35

ICD-10 Finland

Polyuria

2.4

50.4

351

1495

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

50.2

166

467

M01AE02

ATC

naproxen; oral, rectal

1.5

50.0

2650

20933

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

50.0

454

2166

P99

ICPC

Psychological disorders other

3.4

49.9

180

536

SPAT1301

SPAT

No procedures

1.6

49.8

1425

9763

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

49.8

1014

6351

G43

ICD-10 Finland

Migraine

3.1

49.7

219

737

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

5.3

49.5

188

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

49.5

3472

29170

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

8.4

49.3

Z2446

NOMESCO Finland

Social worker

2.5

49.3

336

1417

SFA20

NOMESCO Finland

Two-surface restoration

1.5

49.2

2816

22589

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

49.2

1113

7172

J96.1

ICD-10 Finland

Chronic respiratory failure

4.5

49.2

122

278

R4110, ,

SPAT

2.3

48.9

401

1835

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

7.5

48.7

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.1

48.6

207

683

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.3

48.5

127

302

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

48.4

193

612

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.9

48.4

143

372

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.7

48.4

157

436

A10BX07

ATC

[U] liraglutide

6.7

48.4

117

SPAT1254

SPAT

Administration of medicine

1.9

48.3

686

3848

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

48.0

661

3671

R05

ICD-10 Finland

Cough

1.7

47.7

971

6071

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

47.7

603

3252

SPAT1312

SPAT

General health counselling

1.6

47.7

1494

10446

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.2

47.6

135

L08

ICPC

Shoulder symptom/complaint

1.7

47.5

974

6104

D07AC01

ATC

betamethasone; topical

1.6

47.4

1660

11912

M01AH01

ATC

celecoxib; oral

1.8

47.1

762

4453

UKC02

NOMESCO Finland

Cystoscopy

1.8

46.8

755

4407

M48.0

ICD-10 Finland

Spinal stenosis

2.0

46.8

522

2693

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

46.7

566

3007

S18

ICPC

Laceration/cut

1.5

46.7

2079

15729

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

46.3

411

1942

J01CA04

ATC

amoxicillin; systemic

1.6

45.9

4012

35121

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

45.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

45.9

459

2273

J01FA10

ATC

azithromycin; systemic

1.5

45.8

2700

21656

E0000UV, ,

ATC

1.5

45.7

1924

14358

205

Kela drug reimbursment

Chronic hypertension

1.7

45.7

1093

7132

R07.3

ICD-10 Finland

Other chest pain

2.1

45.7

453

2236

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.2

45.6

180

M02AA07

ATC

piroxicam; topical

1.6

45.3

1533

10889

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

45.2

518

2697

P74

ICPC

Anxiety disorder/anxiety state

2.8

45.1

240

895

N02CC04

ATC

rizatriptan; oral

2.9

45.1

223

800

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

45.1

237

879

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

45.0

503

2596

G04CA02

ATC

tamsulosin; oral

1.7

44.9

1135

7507

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.6

44.8

148

416

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

44.7

760

4504

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

44.7

524

2751

SAA04

NOMESCO Finland

Special examination of mouth

2.5

44.4

283

1155

J46

ICD-10 Finland

Status asthmaticus

3.7

44.3

142

391

G45.4

ICD-10 Finland

Transient global amnesia

12.7

44.3

SPAT1310

SPAT

Counselling related to known health issue

1.6

44.1

1440

10131

C08DA01

ATC

verapamil; systemic

3.1

44.1

185

605

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

6.3

44.0

119

R05

ICPC

Cough

1.7

44.0

1076

7052

R00.2

ICD-10 Finland

Palpitations

2.3

44.0

370

1709

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

43.9

263

1042

R03AC03

ATC

terbutaline; inhalant

1.9

43.9

631

3548

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

43.8

438

2168

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

43.7

505

2636

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.9

43.7

130

340

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

8.3

43.7

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

43.6

617

3451

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.8

43.4

134

360

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

5.2

43.1

174

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

43.1

272

1105

R01AD01

ATC

beclometasone; nasal

1.8

43.1

707

4141

IBA03

NOMESCO Finland

Psychotherapy evaluation

5.9

43.0

132

A10AE04

ATC

insulin glargine; parenteral

2.1

42.6

456

2315

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

42.5

317

1390

C10AA05

ATC

atorvastatin; oral

1.5

42.4

1717

12656

N30.0

ICD-10 Finland

Acute cystitis

1.8

42.3

685

3994

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.7

42.3

135

371

M01AH05

ATC

etoricoxib; oral

1.5

42.3

2833

23167

G04BD08

ATC

solifenacin; oral

2.4

42.2

297

1270

XKD00

NOMESCO Finland

Uroflowmetry

1.8

42.1

780

4733

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

42.1

1035

6784

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

41.9

244

953

KMAK, ,

NOMESCO Finland

1.5

41.8

2437

19356

N06AA10

ATC

nortriptyline; systemic

4.5

41.7

103

234

3074F

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIVALVERYTMIN HÄIRIÖ]

+∞

41.7

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

41.7

H02AB07

ATC

prednisone; oral

1.9

41.6

606

3418

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.3

41.5

156

477

A08AB01

ATC

orlistat; oral

8.2

41.4

N89

ICPC

Migraine

3.6

41.4

140

400

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

41.4

592

3320

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

41.1

445

2267

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.1

41.0

115

288

F51

ICD-10 Finland

Nonorganic sleep disorders

2.7

40.9

225

854

D11

ICPC

Diarrhoea

1.9

40.9

561

3103

E66

ICD-10 Finland

Obesity

2.7

40.8

219

821

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.8

40.8

125

334

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

40.5

1244

8597

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

40.5

1753

13074

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

40.4

250

1006

SPAT1260

SPAT

Consultation of another employee

1.7

40.3

785

4828

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

40.3

1942

14807

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.3

40.1

107

B01AC04

ATC

clopidogrel; oral

1.8

40.0

625

3601

K59.0

ICD-10 Finland

Constipation

2.5

40.0

259

1065

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

4.9

39.9

186

J45

ICD-10 Finland

Asthma

2.0

39.9

457

2376

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

39.9

271

1140

AA400

NOMESCO Finland

Electroconvulsive therapy

6.6

39.5

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

39.5

428

2181

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

39.2

973

6380

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

39.2

1320

9310

Z3231

NOMESCO Finland

Registered nurse

1.6

39.1

1210

8369

SPAT1229

SPAT

Assessment of need for aid

2.3

39.0

322

1474

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.2

39.0

159

511

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.8

39.0

195

704

ZXD20

NOMESCO Finland

Day surgery

1.8

39.0

602

3455

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

5.3

39.0

152

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

39.0

1230

8544

H02AB04

ATC

methylprednisolone; systemic

1.8

39.0

625

3629

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

38.9

432

2220

R5110, ,

SPAT

2.4

38.9

292

1284

162

Kela drug reimbursment

liraglutide

6.1

38.7

111

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

38.7

407

2050

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

38.7

513

2804

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

38.6

1252

8749

M35.7

ICD-10 Finland

Hypermobility syndrome

4.8

38.5

184

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

38.4

339

1595

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.9

38.4

112

289

M01AX17

ATC

nimesulide; oral

1.6

38.3

976

6438

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

6.5

38.3

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.7

38.2

193

G04BD04

ATC

oxybutynin; oral, transdermal

2.6

38.1

224

879

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

38.0

314

1438

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

38.0

854

5453

SFA30

NOMESCO Finland

Three-surface restoration

1.5

38.0

1918

14714

C10AA01

ATC

simvastatin; oral

1.5

38.0

1684

12584

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.1

37.8

164

547

R06AX27

ATC

desloratadine; oral

1.6

37.6

1280

9033

C01DA14

ATC

isosorbide mononitrate; oral

1.8

37.6

605

3514

C08CA13

ATC

lercanidipine; oral

1.9

37.5

565

3215

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.4

37.5

139

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

37.4

366

1794

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.1

37.3

102

251

ZXA10

NOMESCO Finland

Bilateral

1.7

37.2

805

5085

J01MA12

ATC

levofloxacin; systemic

1.7

37.2

803

5071

A10BH01

ATC

sitagliptin; oral

2.0

37.2

415

2136

XG460

NOMESCO Finland

Short time oxymetry

4.4

37.1

214

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.3

36.9

144

451

WX723, ,

SPAT

10.3

36.9

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

36.8

407

2087

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

36.8

496

2723

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

36.8

1312

9350

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

36.6

855

5509

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

36.5

1834

14023

R74

ICPC

Upper respiratory infection acute

1.5

36.2

1444

10533

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

36.1

219

873

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

36.0

310

1444

R25.1

ICD-10 Finland

Tremor, unspecified

3.0

35.9

158

531

D01

ICPC

Abdominal pain/cramps general

1.9

35.8

529

2992

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

6.1

35.7

103

M03BX01

ATC

baclofen; systemic

3.8

35.7

108

286

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

35.7

949

6313

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

35.4

331

1593

-1, ,

NOMESCO Finland

1.5

35.4

1545

11470

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.8

35.4

187

695

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

35.4

385

1962

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.7

35.3

190

713

SPAT1097

SPAT

Recording of ECG

1.8

35.2

595

3505

A02BC04

ATC

rabeprazole; oral

2.0

35.1

390

2002

N06AX17

ATC

milnacipran; oral

5.7

35.1

115

4211

FHL

Transeptal septal resection and reconstruction

5.7

35.1

115

C05AA08

ATC

fluocortolone; rectal, topical

1.8

35.1

598

3530

N02AA05

ATC

oxycodone; systemic

1.7

35.0

728

4545

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

34.9

596

3519

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.0

34.9

428

2275

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

34.9

897

5914

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

34.8

631

3792

K03.00

ICD-10 Finland

Approximal wear

2.1

34.7

344

1693

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.1

34.7

234

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

34.7

246

1055

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.3

34.6

209

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.1

34.6

144

469

Z00.0

ICD-10 Finland

General medical examination

1.6

34.6

869

5697

F41.00

ICD-10 Finland

Moderate panic disorder

4.1

34.5

235

IGY02, ,

SPAT

4.6

34.5

181

L15

ICPC

Knee symptom/complaint

1.6

34.5

983

6644

A46

ICD-10 Finland

Erysipelas

1.8

34.4

621

3727

A10AB05

ATC

insulin aspart; parenteral

2.1

34.3

355

1776

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

34.2

802

5164

SPAT1058

SPAT

PEF monitoring instruction

2.1

34.2

352

1758

WX290

NOMESCO Finland

Other blockage of nerve

1.4

34.2

2195

17525

ZXA05

NOMESCO Finland

Left side

1.6

34.2

1046

7186

M03AX01

ATC

botulinum toxin; parenteral

5.1

34.0

144

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

34.0

581

3431

R51.81

ICD-10 Finland

Facial pain NOS

3.6

33.9

113

320

C03DA01

ATC

spironolactone; oral

1.9

33.9

483

2698

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

5.7

33.9

112

XF402

NOMESCO Finland

ECG with work load test

1.9

33.7

442

2403

SPAT1216

SPAT

Assessment of functional ability

1.8

33.7

610

3663

R13

ICD-10 Finland

Dysphagia

2.2

33.6

300

1418

214

Kela drug reimbursment

Severe and chronic narcolepsy

+∞

33.4

R03DA04

ATC

theophylline; systemic, rectal

2.4

33.3

225

943

C10AA07

ATC

rosuvastatin; oral

1.5

33.3

1290

9322

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

33.2

1239

8883

S29

ICPC

Skin symptom/complaint other

1.6

33.2

843

5537

N05CD02

ATC

nitrazepam; oral

4.2

33.1

212

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

33.0

907

6069

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

33.0

148

503

N07BB01

ATC

disulfiram; oral

2.5

32.8

217

901

J01FA09

ATC

clarithromycin; systemic

1.5

32.6

1346

9848

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.9

32.6

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

32.5

193

761

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

32.5

1539

11573

P20

ICPC

Memory disturbance

1.8

32.4

500

2862

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.0

32.4

139

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

32.3

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

32.3

546

3212

L86

ICPC

Back syndrome with radiating pain

2.3

32.2

261

1185

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.5

32.2

203

824

OAB50, ,

SPAT

2.3

32.2

247

1096

Z29.8

ICD-10 Finland

Other specified prophylactic measures

2.8

32.1

166

610

F33

ICD-10 Finland

Recurrent depressive disorder

3.3

32.1

121

371

M01AC06

ATC

meloxicam; systemic, rectal

1.5

32.1

1514

11369

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

31.8

335

1686

C09CA01

ATC

losartan; oral

1.5

31.8

1034

7188

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

31.6

165

610

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

31.6

195

784

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

31.5

476

2707

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

31.4

1098

7749

Z00.8

ICD-10 Finland

Other general examinations

2.0

31.4

360

1869

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

7.4

31.4

K08.80

ICD-10 Finland

Toothache NOS

1.9

31.3

390

2083

R03AC12

ATC

salmeterol; inhalant

2.5

31.2

195

788

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

31.2

545

3235

G54.0

ICD-10 Finland

Brachial plexus disorders

3.2

31.2

124

393

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

31.1

215

911

Z25.1

ICD-10 Finland

Need for immunization against influenza

2.2

31.1

283

1348

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

31.0

558

3340

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

4.9

30.8

141

T83

ICPC

Overweight

3.6

30.8

104

297

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

5.5

30.8

108

A11

ICPC

Chest pain NOS

2.0

30.7

342

1756

A29

ICPC

General symptom/complaint other

1.8

30.6

544

3244

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.8

30.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.6

30.5

176

684

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.2

30.5

262

1218

R49.01

ICD-10 Finland

Functional dysphonia

2.9

30.5

146

515

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.5

30.5

106

309

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.5

30.4

103

295

F60.5

ICD-10 Finland

Anankastic personality disorder

4.6

30.3

159

R06.2

ICD-10 Finland

Wheezing

2.4

30.2

204

855

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

30.2

119

375

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

30.2

905

6169

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

30.0

1516

11502

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

5.9

30.0

R5140, ,

SPAT

5.7

30.0

100

XQ800

NOMESCO Finland

Prick test

2.0

30.0

326

1660

N02CC05

ATC

almotriptan; oral

3.0

29.9

137

472

ZXA00

NOMESCO Finland

Right side

1.5

29.8

1097

7819

D07AD01

ATC

clobetasol; topical

1.6

29.5

704

4540

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.7

29.5

159

597

N06BA12

ATC

lisdexamfetamine; oral

4.7

29.4

143

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

50.3

29.3

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

29.3

510

3022

J20

ICD-10 Finland

Acute bronchitis

1.9

29.3

424

2377

Z01.7

ICD-10 Finland

Laboratory examination

1.7

29.3

653

4141

NOMESCO Finland

Other rehabilitation services

+∞

29.2

M04AA01

ATC

allopurinol; systemic

1.7

29.1

536

3227

R21

ICPC

Throat symptom/complaint

1.5

29.1

943

6536

N05AD01

ATC

haloperidol; systemic

2.8

29.0

151

557

G44.8

ICD-10 Finland

Other specified headache syndromes

5.4

28.9

107

A10BK03

ATC

empagliflozin; oral

1.9

28.9

395

2175

C08DB01

ATC

diltiazem; oral

2.4

28.9

202

861

N17

ICPC

Vertigo/dizziness

1.8

28.8

478

2792

WVA30, ,

SPAT

2.2

28.8

248

1154

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

28.8

637

4030

N05AF01

ATC

flupentixol; systemic

3.9

28.7

213

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.7

28.7

158

600

C02AC05

ATC

moxonidine; oral

2.5

28.7

187

771

EBA00

NOMESCO Finland

Extraction of tooth

1.4

28.7

1637

12679

XG405

NOMESCO Finland

Education on PEF monitoring

3.9

28.3

211

R06AX22

ATC

ebastine; oral

1.6

28.3

702

4571

R50.9

ICD-10 Finland

Fever, unspecified

1.6

28.2

651

4162

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

28.0

228

1037

A10BB12

ATC

glimepiride; oral

2.1

28.0

280

1382

C03AA03

ATC

hydrochlorothiazide; oral

1.9

27.9

343

1822

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

27.9

192

812

J01EA01

ATC

trimethoprim; systemic

1.5

27.9

1017

7221

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

27.8

678

4392

SPAT1234

SPAT

Support of social functional capacity

2.3

27.8

218

976

R07.0

ICD-10 Finland

Pain in throat

2.0

27.8

312

1607

Z08

ICPC

Social welfare problem

4.1

27.7

192

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

27.7

250

1186

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

27.6

436

2511

C09AA02

ATC

enalapril; systemic

1.6

27.5

761

5081

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.4

27.5

186

781

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.2

27.5

234

1085

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.4

27.4

200

868

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

27.4

449

2612

G04BD07

ATC

tolterodine; oral

2.4

27.4

195

838

A01AB09

ATC

miconazole; local oral

1.9

27.3

347

1864

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

27.3

545

3354

G04BD09

ATC

trospium; oral

3.2

27.2

106

332

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

27.2

3219

28084

XF404

NOMESCO Finland

Ambulatory ECG

1.9

27.1

355

1926

M01AB55

ATC

diclofenac, combinations; oral

2.1

27.1

264

1290

M54.8

ICD-10 Finland

Other dorsalgia

2.4

27.0

198

861

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.9

26.7

123

425

J01DA09

ATC

[U] cefadroxil

1.5

26.6

1135

8305

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

140.7

26.6

R12

ICD-10 Finland

Heartburn

1.9

26.6

337

1809

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

4.6

26.6

135

XKC03

NOMESCO Finland

Water cystometry

2.9

26.6

129

459

L12

ICPC

Hand/finger symptom/complaint

1.6

26.5

683

4483

U02

ICPC

Urinary frequency/urgency

1.7

26.5

553

3443

RK320, ,

NOMESCO Finland

7.6

26.3

L13

ICPC

Hip symptom/complaint

1.6

26.3

692

4564

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.6

26.3

241

J01DA06

ATC

[U] cefuroxime

1.6

26.3

598

3806

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

26.2

137

507

J01CA08

ATC

pivmecillinam; oral

1.4

26.2

1537

11923

XG410

NOMESCO Finland

Flow-volume spirometry

2.5

26.1

170

701

E000001, ,

ATC

1.5

26.1

862

5985

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

26.1

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

26.1

P25

ICPC

Phase of life problem adult

2.3

26.0

193

844

SPAT1153

SPAT

Removal of sutures

1.4

25.9

1306

9854

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

25.9

265

1319

R29

ICPC

Respiratory symptom/complaint other

2.0

25.9

280

1422

N05AL01

ATC

sulpiride; systemic

3.8

25.9

211

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.0

25.8

189

C10AA03

ATC

pravastatin; oral

2.0

25.8

271

1362

H02AB09

ATC

hydrocortisone; systemic

3.0

25.7

115

391

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

5.6

25.6

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.5

25.6

250

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

25.6

1354

10306

SPAT1325

SPAT

Vaccination

1.4

25.5

1403

10752

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

25.4

617

3989

A10BK01

ATC

dapagliflozin; oral

2.0

25.3

289

1496

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

25.3

605

3897

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

25.2

185

806

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

25.1

2264

18809

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

25.0

329

1787

A02BA04

ATC

nizatidine; systemic

2.0

25.0

294

1538

R41.3

ICD-10 Finland

Other amnesia

2.9

25.0

119

419

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

25.0

348

1926

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

24.8

120

426

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.7

24.8

208

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.1

24.8

105

346

Z3226

NOMESCO Finland

Physiotherapist

1.6

24.8

743

5044

M01AH03

ATC

valdecoxib; oral

2.1

24.8

254

1265

X58

ICD-10 Finland

Exposure to other specified factors

1.6

24.7

606

3925

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

24.7

762

5205

R52.1

ICD-10 Finland

Chronic intractable pain

5.1

24.7

100

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

251.4

24.7

WZC00, ,

SPAT

1.7

24.6

449

2692

F32.8

ICD-10 Finland

Other depressive episodes

3.5

24.6

252

R03AC13

ATC

formoterol; inhalant

2.2

24.6

202

923

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.9

24.5

116

407

UDC00

NOMESCO Finland

Ear microscopy

1.9

24.5

315

1698

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.0

24.5

109

370

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

24.5

212

990

A07AA02

ATC

nystatin; oral

2.1

24.4

233

1130

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

5.6

24.4

H57.1

ICD-10 Finland

Ocular pain

2.4

24.3

162

676

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

4.4

24.3

137

L02

ICPC

Back symptom/complaint

1.8

24.2

419

2475

A02BX02

ATC

sucralfate; oral

2.4

24.2

161

671

R06.4

ICD-10 Finland

Hyperventilation

3.7

24.2

212

A01AB04

ATC

amphotericin B; local oral

2.3

24.1

179

783

A10BJ01

ATC

exenatide; parenteral

4.9

24.1

110

G40.10

ICD-10 Finland

Simple partial seizures

+∞

24.0

282

Kela drug reimbursment

Sodium oxybat

+∞

24.0

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

5.1

24.0

SPAT1053

SPAT

Memory test

1.7

24.0

506

3156

SJB60

NOMESCO Finland

Adjustment and grinding of removable appliance

3.6

24.0

218

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

5.6

23.9

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

5.6

23.9

F51.5

ICD-10 Finland

Nightmares

37.7

23.9

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.8

23.9

118

424

K04

ICPC

Palpitations/awareness of heart

2.1

23.9

224

1079

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.4

23.9

A10BX04

ATC

[U] exenatide

4.9

23.9

107

K07.61

ICD-10 Finland

Cracking jaw joint

3.0

23.8

106

360

J01AA07

ATC

tetracycline; systemic

1.6

23.7

636

4206

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

23.7

798

5551

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.5

23.7

229

N06AA22, ,

ATC

5.8

23.6

M01AX05

ATC

glucosamine; oral

1.6

23.5

687

4633

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.9

23.4

113

401

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

23.4

251

1271

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

23.4

142

567

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.7

23.3

117

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.6

23.3

208

N03AX18

ATC

lacosamide; systemic

46.9

23.3

N06BA09

ATC

atomoxetine; oral

7.3

23.3

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

23.2

203

951

N62

ICD-10 Finland

Hypertrophy of breast

2.3

23.2

174

765

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.7

23.2

195

AN1

Coronary angiography

1.7

23.1

429

2583

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

23.1

192

881

S97

ICPC

Chronic ulcer skin

2.0

23.1

244

1229

H02

ICPC

Hearing complaint

1.6

23.1

532

3392

SFA00

NOMESCO Finland

Small restoration

1.6

23.1

599

3931

F06.7

ICD-10 Finland

Mild cognitive disorder

2.8

23.1

116

421

B01AA03

ATC

warfarin; systemic

1.5

23.0

708

4828

3051, ,

Kela drug reimbursment

5.9

23.0

H93.1

ICD-10 Finland

Tinnitus

1.9

23.0

290

1554

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.1

23.0

156

R01AD11

ATC

triamcinolone; nasal

1.8

22.9

352

2007

N07XX04

ATC

sodium oxybate; oral

+∞

22.9

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

22.8

179

802

ZY000

NOMESCO Finland

Hospital inpatient

3.7

22.8

197

A10AC01

ATC

insulin (human); parenteral

1.9

22.7

311

1711

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

22.7

814

5735

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

22.7

395

2337

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

22.7

301

1640

A10BJ05

ATC

dulaglutide; parenteral

3.4

22.6

246

WZC30

NOMESCO Finland

Teaching

1.6

22.6

659

4440

M02AA10

ATC

ketoprofen; topical

1.6

22.6

614

4073

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

22.5

217

1056

K04.08

ICD-10 Finland

Other specified pulpit

1.8

22.5

331

1863

R06AE09

ATC

levocetirizine; oral

1.6

22.5

603

3987

R01AD05

ATC

budesonide; nasal

1.9

22.4

309

1704

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

22.4

290

1567

I95.1

ICD-10 Finland

Orthostatic hypotension

2.5

22.4

141

573

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.3

22.4

163

708

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

45.2

22.3

H02.3

ICD-10 Finland

Blepharochalasis

2.0

22.3

249

1279

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

22.3

115

423

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.7

22.3

123

469

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.3

22.2

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.5

22.2

146

605

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.8

22.2

106

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

22.1

124

476

L60.0

ICD-10 Finland

Ingrowing nail

2.2

22.1

199

944

R03BC03

ATC

nedocromil; inhalant

1.9

22.1

268

1418

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

22.0

305

1684

GX2D5

NOMESCO Finland

Sleep oximetry

7.1

22.0

F61

ICD-10 Finland

Mixed and other personality disorders

7.1

22.0

IER01

NOMESCO Finland

Psychoeducation, group

5.0

22.0

R03BB01

ATC

ipratropium bromide; inhalant

2.4

22.0

149

627

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

21.9

200

953

D07XC01

ATC

betamethasone; topical

1.6

21.9

502

3194

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

4.7

21.9

107

C01CA24

ATC

epinephrine; parenteral

2.0

21.9

260

1365

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

21.8

1131

8537

R5599

NOMESCO Finland

Other rehabilitation service

2.6

21.8

123

474

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.2

21.8

180

825

B01AB05

ATC

enoxaparin; parenteral

1.4

21.7

1250

9605

M54

ICD-10 Finland

Dorsalgia

1.6

21.7

509

3256

ZXD05

NOMESCO Finland

Urgent procedure

1.4

21.7

1293

9997

G40

ICD-10 Finland

Epilepsy

80.5

21.7

SGA01

NOMESCO Finland

Emergency treatment

1.5

21.7

696

4788

F45.0

ICD-10 Finland

Somatization disorder

7.7

21.7

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

21.6

316

1774

A05

ICPC

Feeling ill

1.9

21.6

261

1378

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

21.6

131

523

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

21.6

138

565

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

21.6

645

4368

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

21.6

416

2531

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.4

21.5

234

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

21.5

135

548

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.4

21.5

125

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

21.5

379

2250

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

21.4

103

365

SPAT1255

SPAT

Intravenous administration of medicine

1.9

21.4

282

1533

ZXC10

NOMESCO Finland

Use of laser

2.8

21.3

104

372

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

6.8

21.2

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

6.0

21.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.0

21.2

243

1261

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

21.1

1279

9907

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

21.0

238

1229

H01

ICPC

Ear pain/earache

1.6

21.0

470

2973

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

21.0

464

2926

L29

ICPC

Musculoskeletal sympt/complt other

1.8

21.0

340

1970

SPAT1284

SPAT

Extensive health certificate

2.5

21.0

128

513

G04CA01

ATC

alfuzosin; oral

1.6

20.9

544

3569

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

20.9

233

1197

N39.3

ICD-10 Finland

Stress incontinence

1.9

20.8

251

1324

G41.9

ICD-10 Finland

Status epilepticus, unspecified

+∞

20.8

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

20.8

R4110

NOMESCO Finland

Physiotherapy

1.4

20.8

1143

8708

QDH05

NOMESCO Finland

Correction of deformity of toe nail

7.4

20.8

S80.0

ICD-10 Finland

Contusion of knee

1.8

20.7

293

1628

S22.3

ICD-10 Finland

Fracture of rib

1.8

20.7

294

1637

D01AC02

ATC

miconazole; topical

1.8

20.6

316

1800

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

20.6

498

3210

C08CA02

ATC

felodipine; oral

1.8

20.5

346

2027

D07AC13

ATC

mometasone; topical

1.4

20.5

1197

9209

R06AX13

ATC

loratadine; oral

1.5

20.5

615

4167

K07.4

ICD-10 Finland

Malocclusion, unspecified

3.2

20.5

257

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

20.4

370

2212

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

20.4

106

392

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.3

20.4

122

M10.9

ICD-10 Finland

Gout, unspecified

1.9

20.3

266

1442

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

20.3

501

3243

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

20.3

579

3877

N02CC02

ATC

naratriptan; oral

3.8

20.2

162

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

20.2

426

2654

R25.2

ICD-10 Finland

Cramp and spasm

2.7

20.1

105

389

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

20.1

209

1047

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.5

20.0

128

524

U04

ICPC

Incontinence urine

2.1

19.9

192

935

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

19.9

305

1738

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.6

19.8

104

SXC05

NOMESCO Finland

Other oral or dental procedure

1.8

19.8

279

1549

D09

ICPC

Nausea

2.1

19.8

197

971

ACC51

NOMESCO Finland

Release of median nerve

1.8

19.8

285

1593

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

19.8

521

3425

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

19.8

223

1150

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.8

19.7

354

H29

ICPC

Ear symptom/complaint other

1.6

19.7

451

2867

207

Kela drug reimbursment

Chronic arrhythmias

1.6

19.7

555

3706

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.9

19.6

SJB10

NOMESCO Finland

Fitting of removable appliance incl. patient instructions, demanding

4.8

19.6

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

19.6

231

1210

F31

ICD-10 Finland

Bipolar affective disorder

3.6

19.6

175

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

19.6

363

2185

D02

ICPC

Abdominal pain epigastric

1.9

19.5

244

1303

SPAT1139

SPAT

Nutrition survey

2.4

19.5

129

537

F41.01

ICD-10 Finland

Severe panic disorder

5.0

19.5

ZXY60

NOMESCO Finland

2-person team, nurses

5.7

19.4

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.3

19.4

114

K04.0

ICD-10 Finland

Pulpitis

1.7

19.4

391

2406

EMB10

NOMESCO Finland

Tonsillectomy

1.9

19.4

249

1342

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

19.4

285

1604

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

4.5

19.3

102

D02AE01

ATC

carbamide; topical

1.8

19.2

271

1506

B02AA02

ATC

tranexamic acid; systemic

1.5

19.1

551

3696

F50.8

ICD-10 Finland

Other eating disorders

6.7

19.1

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

6.7

19.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

19.1

644

4469

N05AB01

ATC

dixyrazine; systemic

3.5

19.1

183

U07

ICPC

Urine symptom/complaint other

1.8

19.1

288

1634

A97

ICPC

No disease

1.5

19.1

739

5274

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.1

19.0

248

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.8

19.0

151

D19

ICPC

Teeth/gum symptom/complaint

1.4

18.9

1197

9312

N07CA01

ATC

betahistine; oral

1.8

18.9

273

1528

M54.3

ICD-10 Finland

Sciatica

1.9

18.9

235

1254

W19

ICD-10 Finland

Unspecified fall

1.7

18.9

388

2400

R4120

NOMESCO Finland

Occupational therapy

1.9

18.9

257

1412

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.3

18.8

146

652

E000006, ,

ATC

1.9

18.8

262

1450

34609

ICD-8 Finland

Migraine, Unspecified

+∞

18.8

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

18.8

H81.3

ICD-10 Finland

Other peripheral vertigo

2.6

18.7

110

433

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

18.7

588

4019

A06AC51

ATC

ispaghula, combinations; oral

2.1

18.7

184

904

A10AE05

ATC

insulin detemir; parenteral

1.9

18.6

222

1168

R03CA02

ATC

ephedrine; oral

20.9

18.6

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.8

18.6

321

Z29

ICPC

Social problem NOS

2.7

18.5

102

389

K29.7

ICD-10 Finland

Gastritis, unspecified

2.3

18.5

143

638

A41.9

ICD-10 Finland

Sepsis, unspecified

2.2

18.5

148

670

L14

ICPC

Leg/thigh symptom/complaint

1.8

18.5

302

1754

S22

ICPC

Nail symptom/complaint

1.8

18.4

259

1437

S02

ICPC

Pruritus

2.2

18.4

150

684

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

18.4

238

1286

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.9

18.4

290

N05CD08

ATC

midazolam; nasal, systemic

2.9

18.4

312

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

18.3

285

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

18.3

240

1303

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

18.3

271

1529

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.3

18.3

203

N02AC04

ATC

dextropropoxyphene; oral

2.3

18.2

134

585

N88

ICPC

Epilepsy

44.1

18.2

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

6.0

18.2

M54.1

ICD-10 Finland

Radiculopathy

2.2

18.2

157

733

F51.1

ICD-10 Finland

Nonorganic hypersomnia

19.4

18.2

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.0

18.1

129

L18

ICPC

Muscle pain

2.1

18.1

165

787

N04BD01

ATC

selegiline; oral

3.1

18.1

250

B01AC07

ATC

dipyridamole; systemic

2.4

18.0

125

532

N05AB04

ATC

prochlorperazine; systemic, rectal

3.0

18.0

272

D01BA02

ATC

terbinafine; oral

1.4

18.0

1052

8073

I50.0

ICD-10 Finland

Congestive heart failure

1.9

17.9

248

1369

PA6AD

NOMESCO Finland

CT of neck arteries

2.8

17.9

322

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

17.9

446

2894

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.3

17.9

129

559

M43.1

ICD-10 Finland

Spondylolisthesis

2.2

17.8

154

719

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

6.7

17.8

R30.0

ICD-10 Finland

Dysuria

2.1

17.8

178

879

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

17.8

388

2436

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.0

17.8

122

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

17.7

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

17.7

151

702

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

17.7

437

2829

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

17.6

889

6649

J01MA14

ATC

moxifloxacin; systemic

1.7

17.6

351

2152

C09AA05

ATC

ramipril; oral

1.4

17.6

924

6957

D06

ICPC

Abdominal pain localized other

1.7

17.6

341

2075

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

17.6

1167

9129

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

17.6

219

1169

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.5

17.5

111

453

R52.0

ICD-10 Finland

Acute pain

2.3

17.5

137

614

F84.5

ICD-10 Finland

Asperger syndrome

4.9

17.5

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.6

17.5

155

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

17.5

891

6674

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

180.6

17.5

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

17.5

174

858

SPAT1059

SPAT

Spirometry at the office

2.0

17.5

199

1030

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

17.5

144

660

A99

ICPC

Disease/condition unspecnature/site

1.7

17.5

360

2228

SDA03

NOMESCO Finland

Periodontal treatment

1.3

17.4

1724

14288

R4190

NOMESCO Finland

Nutritional therapy

2.1

17.4

156

739

K07

ICPC

Swollen ankles/oedema

2.1

17.4

165

799

K89

ICPC

Transient cerebral ischaemia

5.9

17.4

C08CA05

ATC

nifedipine; systemic

1.9

17.4

227

1230

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.2

17.4

111

N05CD05

ATC

triazolam; oral, sublingual

3.5

17.4

175

C07AG02

ATC

carvedilol; oral

1.9

17.4

210

1110

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.7

17.3

333

R33

ICD-10 Finland

Retention of urine

1.7

17.3

326

1969

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.9

17.3

289

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

17.3

233

1276

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

17.3

180

903

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

17.1

117

495

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

5.8

17.1

S82

ICPC

Naevus/mole

1.5

17.1

548

3760

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

17.1

826

6132

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

17.1

1489

12122

R04.2

ICD-10 Finland

Haemoptysis

2.2

17.1

138

628

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.8

17.0

135

N05AE04

ATC

ziprasidone; systemic

4.7

17.0

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

17.0

216

1161

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

50.2

17.0

K80

ICPC

Cardiac arrhythmia NOS

1.7

17.0

297

1759

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

17.0

957

7291

R5599, ,

SPAT

6.9

17.0

N04BC04

ATC

ropinirole; oral

3.4

17.0

173

K07.23

ICD-10 Finland

Deep bite

2.6

16.9

100

395

J01FA01

ATC

erythromycin; systemic

1.5

16.9

567

3925

-50

ICPC

Medication/prescr/renewal

2.1

16.9

160

775

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.4

16.9

117

498

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

16.9

535

3662

C10AC01

ATC

colestyramine; oral

2.5

16.8

108

444

H92.0

ICD-10 Finland

Otalgia

1.8

16.8

241

1346

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

16.8

337

2072

SPAT1238

SPAT

Brief therapy

2.9

16.8

267

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

16.7

294

1743

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.3

16.7

132

595

3074G

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNISSAKÄVELYHÄIRIÖ JA YÖLLINEN KAUHUKOHTAUS]

+∞

16.7

IGV01

NOMESCO Finland

Psychiatric network contact

3.6

16.7

151

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

16.7

287

1692

N30

ICD-10 Finland

Cystitis

1.7

16.6

298

1776

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

16.6

447

2952

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

16.6

447

2953

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.6

16.5

353

N02AJ13

ATC

tramadol and paracetamol; systemic

2.7

16.5

319

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

16.5

155

749

XF409

NOMESCO Finland

Other special ECG

5.6

16.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

16.4

323

1974

R19.4

ICD-10 Finland

Change in bowel habit

2.4

16.4

115

492

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

16.4

270

1571

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.4

16.4

167

N05AC02

ATC

thioridazine; oral

2.6

16.4

378

R31

ICD-10 Finland

Unspecified haematuria

1.6

16.4

397

2558

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

16.4

193

1012

N29

ICPC

Neurological sympt/complt other

2.8

16.3

293

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.5

16.3

158

H53.2

ICD-10 Finland

Diplopia

2.4

16.3

116

500

WX002

NOMESCO Finland

Sedation and analgesia

1.4

16.3

748

5498

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

16.3

242

1367

N05AX15

ATC

cariprazine; oral

6.3

16.3

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

16.3

189

986

OAB42, ,

SPAT

1.6

16.2

418

2731

C09CA03

ATC

valsartan; oral

1.7

16.2

342

2128

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.8

16.2

126

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.5

16.2

392

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

16.2

497

3378

R44.1

ICD-10 Finland

Visual hallucinations

5.8

16.2

A08

ICPC

Swelling

2.0

16.1

177

905

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.8

16.1

295

SPAT1104

SPAT

Monitoring of emergency patient

1.8

16.1

242

1372

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

16.1

115

497

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

16.0

957

7350

N04AA02

ATC

biperiden; systemic

2.6

16.0

347

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

16.0

223

1234

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.6

16.0

141

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

16.0

172

874

A03

ICPC

Fever

1.4

16.0

702

5119

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

15.9

241

1368

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.3

15.9

A02BA03

ATC

famotidine; systemic

2.2

15.9

132

607

D82

ICPC

Teeth/gum disease

1.3

15.9

1571

12980

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

15.9

331

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

15.9

379

2431

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

15.9

146

699

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

4.0

15.9

110

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.3

15.9

EB1VA, ,

NOMESCO Finland

1.5

15.9

488

3316

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

15.9

508

3482

R15

ICD-10 Finland

Faecal incontinence

2.5

15.9

102

420

P73

ICPC

Affective psychosis

5.7

15.8

U71

ICPC

Cystitis/urinary infection other

1.8

15.8

233

1312

F48.0

ICD-10 Finland

Neurasthenia

14.5

15.8

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

15.8

907

6923

N02CD02

ATC

galcanezumab; parenteral

60.2

15.7

C10AA04

ATC

fluvastatin; oral

1.7

15.7

295

1780

G04BD11

ATC

fesoterodine; oral

2.4

15.7

109

465

B01AF02

ATC

apixaban; oral

1.5

15.7

438

2915

D12

ICPC

Constipation

2.1

15.7

142

677

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

15.6

259

1510

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

15.6

227

1273

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

15.6

4317

40663

S16

ICPC

Bruise/contusion

2.3

15.6

118

522

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.8

15.6

C09DA01

ATC

losartan and diuretics; oral

1.6

15.6

376

2418

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

15.6

122

548

H13

ICPC

Plugged feeling ear

1.4

15.6

753

5582

R30.1

ICD-10 Finland

Vesical tenesmus

2.6

15.6

329

G43.2

ICD-10 Finland

Status migrainosus

85.3

15.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

15.6

235

1334

WZA00

NOMESCO Finland

Concise certificate

1.7

15.5

263

1543

R07.2

ICD-10 Finland

Precordial pain

2.7

15.5

318

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

3.8

15.5

121

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

15.5

296

A10BB01

ATC

glibenclamide; oral

2.2

15.5

133

621

F40.1

ICD-10 Finland

Social phobias

2.3

15.4

112

487

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.3

15.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

15.4

151

741

SPAT1283

SPAT

Restricted health certificate

1.4

15.4

712

5236

I95.9

ICD-10 Finland

Hypotension, unspecified

3.0

15.4

215

U01

ICPC

Dysuria/painful urination

1.7

15.4

281

1684

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.5

15.4

378

Z73.0

ICD-10 Finland

Burn-out

2.0

15.4

157

783

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.8

15.3

122

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

15.3

414

2734

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.6

15.3

326

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

15.3

238

1363

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

15.3

241

1386

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.7

15.2

132

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

15.2

156

780

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

15.2

229

1300

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.3

15.1

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

15.1

106

455

D07AB08

ATC

desonide; topical

1.5

15.0

431

2884

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.9

15.0

176

921

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

15.0

558

3941

M01AX01

ATC

nabumetone; oral

2.1

14.9

148

730

IEV99

NOMESCO Finland

Other psychiatric network intervention

4.5

14.9

S20.2

ICD-10 Finland

Contusion of thorax

1.8

14.9

207

1145

K11.2

ICD-10 Finland

Sialoadenitis

2.1

14.9

132

624

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.4

14.9

104

445

D01AE15

ATC

terbinafine; topical

1.7

14.9

276

1662

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

14.9

384

2511

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

3.8

14.8

116

L09

ICPC

Arm symptom/complaint

1.9

14.8

185

990

JAH01

NOMESCO Finland

Laparoscopy

1.9

14.7

174

913

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

14.7

407

2701

L16

ICPC

Ankle symptom/complaint

1.5

14.7

427

2864

S21

ICPC

Skin texture symptom/complaint

1.5

14.7

552

3904

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

14.7

1065

8412

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

4.9

14.7

315

Kela drug reimbursment

Clopidogrel

4.9

14.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

14.7

165

851

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.8

14.7

248

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.3

14.7

114

511

G47

ICD-10 Finland

Sleep disorders

13.2

14.7

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

14.6

316

1980

U05

ICPC

Urination problems other

1.9

14.6

192

1045

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.9

14.6

176

931

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

14.6

168

875

I20.09

ICD-10 Finland

Unstable angina

1.9

14.6

195

1067

N02CX04, ,

ATC

3.0

14.5

217

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

14.5

201

1111

P58

ICPC

Psychological, Therapeutic counselling/listening

2.5

14.5

347

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.9

14.4

234

C09DA06

ATC

candesartan and diuretics; oral

1.7

14.4

261

1561

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

3.7

14.4

123

A12BA01

ATC

potassium chloride; oral

2.1

14.4

137

666

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

14.4

435

2945

J05AB01

ATC

aciclovir; systemic

1.4

14.4

834

6367

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

14.3

133

640

C10AX09

ATC

ezetimibe; oral

1.5

14.3

542

3839

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.9

14.3

219

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

14.3

679

5015

D07AA02

ATC

hydrocortisone; topical

1.5

14.3

550

3910

L29.9

ICD-10 Finland

Pruritus, unspecified

2.3

14.3

105

460

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

4.4

14.2

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

14.2

399

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

14.2

215

1222

G83.4

ICD-10 Finland

Cauda equina syndrome

6.2

14.2

IHZ05, ,

SPAT

2.0

14.2

150

758

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

14.2

363

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.3

14.2

110

493

A10BX01

ATC

guar gum; oral

2.1

14.1

129

617

F22.0

ICD-10 Finland

Delusional disorder

2.9

14.1

226

SPAT1043

SPAT

Audiometry

1.6

14.1

366

2397

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

14.0

370

2430

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

14.0

353

2294

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.3

14.0

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.3

14.0

K02

ICPC

Pressure/tightness of heart

2.5

14.0

353

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

14.0

130

626

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.8

14.0

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

10.9

14.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.2

13.9

175

N05AD03

ATC

melperone; systemic

3.4

13.9

150

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

5.2

13.9

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

13.8

193

1070

SPAT1050

SPAT

Extensive neurological examination

2.6

13.8

308

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.7

13.8

285

N05BA09

ATC

clobazam; oral

17.6

13.8

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.4

13.8

146

OAB93, ,

SPAT

1.8

13.8

216

1240

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

13.8

177

956

L30.4

ICD-10 Finland

Erythema intertrigo

3.0

13.8

192

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.8

13.8

235

S06

ICPC

Rash localized

1.8

13.7

213

1219

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

6.2

13.7

ZXE00

NOMESCO Finland

One hour or less

1.3

13.7

1580

13260

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.7

892

6930

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.8

13.7

215

1236

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

6.5

13.6

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

13.6

144

728

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

13.5

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

13.5

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

13.5

359

2362

XCK00

NOMESCO Finland

Perimetry

1.8

13.5

221

1285

GX1K5

NOMESCO Finland

Diffusion capacity

4.5

13.5

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

13.5

505

3570

R06AX26

ATC

fexofenadine; oral

1.7

13.5

262

1598

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

13.4

173

935

F43.8

ICD-10 Finland

Other reactions to severe stress

2.2

13.4

107

485

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

16.2

13.4

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

13.4

176

957

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

13.4

279

1731

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.2

13.4

C05AA01

ATC

hydrocortisone; rectal, topical

1.8

13.4

187

1037

A10BH05

ATC

linagliptin; oral

1.9

13.4

170

915

SPAT1252

SPAT

Overall medication plan or its review

1.7

13.4

229

1349

N03AX15

ATC

zonisamide; oral

25.8

13.3

4479

FHL

Other measure in this category

25.8

13.3

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

13.3

311

1985

SGC10

NOMESCO Finland

Pulp capping

1.6

13.3

359

2370

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.4

13.3

G03DB01

ATC

dydrogesterone; oral

1.5

13.3

412

2803

P28

ICPC

Limited function/disability (P)

3.5

13.3

130

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

13.3

494

3486

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

13.3

298

1884

7807A

ICD-9 Finland

General symptoms, Malaise and fatigue

6.3

13.3

N48.1

ICD-10 Finland

Balanoposthitis

2.2

13.3

112

520

SPAT1251

SPAT

Organisation of medication

2.1

13.3

128

626

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

13.3

145

742

WX892

NOMESCO Finland

Monitored bed care

1.6

13.3

276

1713

R03DC01

ATC

zafirlukast; oral

2.9

13.3

207

C09BA02

ATC

enalapril and diuretics; systemic

1.6

13.2

287

1799

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.6

13.2

297

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.3

13.2

102

456

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

13.2

412

N05AA01

ATC

chlorpromazine; systemic, rectal

2.9

13.2

218

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.0

13.2

186

IEY01

NOMESCO Finland

Psychoeducation, individual

3.9

13.2

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.6

13.2

121

A10AB04

ATC

insulin lispro; parenteral

2.1

13.2

124

600

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

13.2

352

2318

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

13.2

394

E29.1

ICD-10 Finland

Testicular hypofunction

3.1

13.2

181

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

13.2

408

2776

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

13.2

209

1205

K92.1

ICD-10 Finland

Melaena

1.8

13.1

197

1117

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

13.1

1025

8169

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

13.1

102

458

N05AF05

ATC

zuclopenthixol; systemic

3.3

13.1

151

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.8

13.0

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.5

13.0

EB1HA, ,

SPAT

2.4

13.0

347

EEC05

NOMESCO Finland

Le Fort I osteotomy

5.9

13.0

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

5.9

13.0

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.4

13.0

384

S10

ICPC

Boil/carbuncle

1.7

13.0

223

1314

F50.9

ICD-10 Finland

Eating disorder, unspecified

3.4

13.0

132

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

13.0

234

1398

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

13.0

195

1106

H50.52

ICD-10 Finland

Exophoria

3.2

13.0

152

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

12.9

121

585

ZXY56

NOMESCO Finland

2-person team, nurse-psychologist

6.1

12.9

F98.8

ICD-10 Finland

Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

6.1

12.9

E000002, ,

ATC

1.5

12.9

428

2953

J01MA06

ATC

norfloxacin; oral

1.5

12.9

449

3128

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

12.9

110

513

F05.9

ICD-10 Finland

Delirium, unspecified

2.5

12.9

307

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.7

12.8

244

A10BG03

ATC

pioglitazone; oral

2.3

12.8

424

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.4

12.8

138

L05

ICPC

Flank/axilla symptom/complaint

1.7

12.8

220

1297

Z2221

NOMESCO Finland

Medical doctor

1.3

12.8

1087

8758

S04

ICPC

Lump/swelling localized

1.5

12.8

404

2759

F43.00

ICD-10 Finland

Acute stress reaction mild

2.2

12.8

105

482

I20.00

ICD-10 Finland

Unstable angina

2.2

12.8

102

463

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

12.8

375

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

12.7

138

704

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

12.7

352

2337

M01AE51

ATC

ibuprofen, combinations; systemic

2.9

12.7

212

TLC02

NOMESCO Finland

Simple extraction of IUD

2.0

12.6

138

706

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

4.3

12.6

F32.0

ICD-10 Finland

Mild depressive episode

2.2

12.6

109

511

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

12.6

860

6718

N05BB01

ATC

hydroxyzine; systemic

1.7

12.6

238

1440

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

12.6

103

473

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.0

12.5

138

708

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

12.5

389

2647

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

12.5

147

771

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.7

12.5

102

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

12.5

415

2863

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.6

12.5

116

3074H

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[PARASOMNIA NUD]

+∞

12.5

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

12.5

AA43B, ,

NOMESCO Finland

+∞

12.5

C01BC04

ATC

flecainide; systemic

2.1

12.5

120

586

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

12.5

408

2806

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.7

12.5

242

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

12.5

146

765

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

6.2

12.5

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

12.4

1394

11631

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.3

12.4

424

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.0

12.4

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

5.0

12.4

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

12.4

120

588

D06AX01

ATC

fusidic acid; topical

1.5

12.4

367

2474

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

12.4

110

522

G25.0

ICD-10 Finland

Essential tremor

2.2

12.3

444

J02AC02

ATC

itraconazole; systemic

1.4

12.3

660

4966

P18

ICPC

Medication abuse

3.8

12.3

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

12.3

326

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.6

12.3

267

G04CB01

ATC

finasteride; oral

1.5

12.3

434

3032

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

4.1

12.3

K29.1

ICD-10 Finland

Other acute gastritis

3.0

12.3

173

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

3.8

12.2

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

3.6

12.2

113

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

12.2

257

1599

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.1

12.2

168

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.1

12.2

115

558

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.1

12.2

A08AA02

ATC

fenfluramine; oral

3.7

12.2

104

F29

ICPC

Eye symptom/complaint other

1.5

12.2

354

2376

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.7

12.2

234

RD210, ,

NOMESCO Finland

2.5

12.2

304

D01AE16

ATC

amorolfine; topical

1.5

12.2

430

3005

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

12.1

235

1432

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.0

12.1

134

689

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

12.1

189

1085

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

12.1

163

895

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

12.1

219

1311

SPAT1211

SPAT

Application of soft bandage

1.6

12.1

320

2105

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

12.0

413

2868

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.8

12.0

202

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.2

12.0

149

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.9

12.0

154

832

R28

ICPC

Limited function/disability (R)

3.0

12.0

170

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

12.0

370

2515

SPAT1281

SPAT

Other administrative function

1.6

12.0

286

1836

M10.0

ICD-10 Finland

Idiopathic gout

2.0

12.0

131

671

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

12.0

247

1530

K07.6

ICD-10 Finland

Temporomandibular joint disorders

3.6

12.0

110

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.2

12.0

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.8

11.9

169

942

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

2.4

11.9

343

SJX10

NOMESCO Finland

Orthodontic treatment/control appointment, short

2.0

11.9

122

610

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

5.7

11.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

11.9

325

2151

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.5

11.9

295

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

3.2

11.9

150

G04CB02

ATC

dutasteride; oral

1.6

11.9

305

1991

R4130

NOMESCO Finland

Speech therapy

2.2

11.9

432

N03AB02

ATC

phenytoin; systemic

4.7

11.9

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

11.9

204

1204

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

11.9

426

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

11.8

184

1055

B35.3

ICD-10 Finland

Tinea pedis

1.8

11.8

170

952

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.5

11.8

111

SPAT1131

SPAT

Colonoscopy

2.1

11.8

112

545

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

11.8

257

1614

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.0

11.8

128

654

W17

ICD-10 Finland

Other fall from one level to another

1.8

11.8

178

1012

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

5.9

11.8

M01AC01

ATC

piroxicam; systemic, rectal

1.4

11.8

467

3335

SPAT1285

SPAT

Provision of consultation response

1.8

11.8

191

1109

N94.1

ICD-10 Finland

Dyspareunia

2.8

11.8

210

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

11.8

739

5699

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

11.8

734

5655

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

11.7

377

R2110

NOMESCO Finland

Giving the first information

1.6

11.7

239

1476

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

11.7

315

2078

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

4.2

11.7

S03.0

ICD-10 Finland

Dislocation of jaw

3.8

11.7

UJH02

NOMESCO Finland

Anoscopy

1.9

11.7

145

775

E03

ICD-10 Finland

Other hypothyroidism

1.7

11.7

202

1194

P02

ICPC

Acute stress reaction

1.7

11.6

190

1105

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

16.4

11.6

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

11.6

629

4738

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.7

11.6

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.7

11.6

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4033

29852

2.61

176.23

4.9

3.6

14.66

14.73

pmol/l

1.03

3777

27171

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1810

9861

2.29

160.35

2.4

2.0

198.15

241.04

u/l

0.80

1707

9205

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2452

15158

2.18

158.10

2.6

2.2

76.97

76.27

nmol/l

0.57

2295

13742

(3013707) Erythrocyte sedimentation rate by Westergren method

3880

28841

2.40

157.00

4.9

3.7

11.31

11.55

mm/h

0.50

3667

26672

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3981

29952

2.45

156.24

8.1

7.4

77.24

78.21

u/l

0.60

3834

28263

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2783

18147

2.16

155.54

7.8

6.7

1.22

1.21

mmol/l

2.02

2400

15504

(3030981) Hyaline casts [#/volume] in Urine by Automated count

604

1945

3.38

150.69

3.5

2.8

0.31

0.25

e6/l

0.32

593

1893

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2561

16309

2.13

150.54

6.7

6.0

1.21

mmol/l

1.43

2376

14935

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2363

14723

2.12

145.64

2.2

1.9

98.11

94.36

pmol/l

3.33

1325

7821

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1471

7599

2.31

145.40

1.8

1.6

8903430.07

20771934.54

pmol/l

0.83

1258

6403

(3036481) Cortisol [Moles/volume] in Serum or Plasma

791

3046

2.89

144.79

2.2

360.31

383.15

nmol/l

2.50

731

2790

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1968

11586

2.13

139.24

3.1

2.5

58.65

60.06

u/l

0.15

1843

10737

(3013826) Glucose [Moles/volume] in Serum or Plasma

3165

22238

2.10

138.52

5.6

4.4

6.69

6.68

mmol/l

0.04

3001

20618

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2155

13202

2.09

136.46

4.6

3.1

73.71

91.77

ng/l

0.14

1373

8643

(3015377) Calcium [Moles/volume] in Serum or Plasma

2037

12225

2.10

136.26

2.9

3.5

2.34

2.35

mmol/l

1.78

1855

10843

(3019309) Folate [Moles/volume] in Red Blood Cells

1266

6308

2.33

134.77

1.8

1.7

1244.55

1152.36

nmol/l

2.86

1006

4780

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4489

36651

2.74

131.89

6.0

4.2

2.31

2.20

mu/l

0.08

4224

33599

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

546

1796

3.28

130.93

4.3

5.23

5.08

kpa

3.32

524

1704

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

528

1704

3.34

130.59

4.1

4.3

1.79

1.83

mmol/l

0.08

379

1232

(3009343) pH of Capillary blood

540

1771

3.29

130.09

4.2

4.3

7.40

7.42

2.01

228

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2578

17069

2.02

129.66

3.6

2.7

111.08

131.81

ug/l

5.73

2439

15913

(3021601) Nitrite [Presence] in Urine by Test strip

2801

19158

2.01

127.78

5.7

4.5

0.00

estimate

0.80

559

3525

(3009261) Glucose [Presence] in Urine by Test strip

2824

19379

2.01

127.54

4.3

3.3

0.01

0.00

estimate

0.25

527

3442

(3019150) Specific gravity of Urine by Refractometry

1516

8300

2.17

127.17

4.3

3.6

1.02

kg/l

0.88

202

1250

(3021960) Folate [Moles/volume] in Serum or Plasma

1496

8165

2.17

126.37

1.7

1.5

20.87

20.06

nmol/l

1.00

1345

7019

(3035350) Ketones [Presence] in Urine by Test strip

2797

19185

2.00

125.83

4.3

3.3

0.00

estimate

2.34

593

3718

(3024561) Albumin [Mass/volume] in Serum or Plasma

2458

16126

2.00

125.54

5.1

35.73

35.54

g/l

0.95

2299

15011

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1655

9506

2.09

121.47

3.5

2.9

1268.88

1561.57

ng/l

1.69

1405

8192

(3029937) Albumin [Presence] in Urine by Test strip

1735

10159

2.07

120.75

4.4

3.6

0.00

estimate

1.94

537

3385

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2054

12886

1.99

116.90

3.6

3.2

32.34

35.96

u/l

0.55

1949

12252

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2813

19639

1.95

116.75

5.9

6.4

10.90

11.97

umol/l

3.66

2681

18684

(3013115) Eosinophils [#/volume] in Blood

2887

20352

1.95

116.19

6.6

6.1

0.20

0.19

e9/l

2.19

2597

17887

(1002224) Polysomnography panel

354

951

3.92

115.13

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

2494

16876

1.93

112.02

15.5

13.8

1.23

1.26

inr

0.98

722

4846

(3031040) Bacteria [#/volume] in Urine by Automated count

3423

25735

1.98

111.95

5.8

3.9

372.04

1922.77

e6/l

2.32

215

317

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2247

14781

1.92

109.04

4.4

3.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3549

27201

1.98

107.32

5.2

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2647

18445

1.89

106.87

6.7

6.4

—

(3019198) Lymphocytes [#/volume] in Blood

2845

20323

1.89

105.97

6.5

5.9

1.98

1.92

e9/l

0.79

2584

18029

(3001604) Monocytes [#/volume] in Blood

2775

19671

1.89

105.81

6.4

5.9

0.58

e9/l

0.16

2477

17038

(3006315) Basophils [#/volume] in Blood

2777

19708

1.89

105.31

6.4

5.9

0.04

e9/l

0.70

2481

17067

(3022313) Gas panel - Capillary blood

395

1235

3.38

102.12

4.2

4.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1104

5819

2.14

98.61

2.8

2.5

13.89

13.41

umol/l

1.35

1044

5449

(3041096) Erythrocytes [Presence] in Urine by Automated

1704

10492

1.93

98.52

4.0

3.0

—

(3015736) pH of Urine

2280

15432

1.86

98.07

3.9

3.0

5.95

5.87

0.48

149

1278

(3018095) Leukocytes [#/volume] in Urine

2079

13699

1.87

97.15

4.8

3.5

63.73

96.59

e6/l

1.67

1608

9524

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1036

5395

2.15

95.09

2.8

2.5

2.40

2.31

g/l

6.19

972

5003

(3018418) pH of Serum or Plasma

1708

10644

1.90

94.35

4.3

4.1

7.40

0.11

326

1926

(3022096) Basophils/100 leukocytes in Blood

2538

17903

1.82

94.14

6.6

6.2

0.65

0.67

1.36

2387

16742

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3490

27162

1.88

93.61

3.9

2.9

47.45

46.18

u/l

0.36

3305

25415

(3019069) Monocytes/100 leukocytes in Blood

2611

18632

1.81

92.68

6.9

6.4

8.45

8.60

1.73

2470

17495

(3002582) Erythrocytes [#/volume] in Urine

1823

11656

1.87

92.59

3.9

3.1

40.46

102.12

e6/l

2.93

1497

8864

(3006504) Eosinophils/100 leukocytes in Blood

2597

18524

1.81

92.11

6.6

6.1

2.92

2.84

1.02

2451

17355

(3002030) Lymphocytes/100 leukocytes in Blood

2669

19243

1.80

90.85

6.7

6.1

28.30

28.09

0.45

2532

18115

(3018010) Neutrophils/100 leukocytes in Blood

2637

18954

1.80

90.60

6.5

5.9

57.16

57.11

0.07

2500

17826

(3013650) Neutrophils [#/volume] in Blood by Automated count

3054

22941

1.81

90.35

9.1

9.4

4.15

4.09

e9/l

0.57

2741

20040

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4538

39051

2.36

87.56

5.3

4.0

5.99

5.87

mmol/l

7.50

4250

35762

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

971

5091

2.12

86.76

2.1

1.7

1.46

1.44

0.57

893

4519

(3019550) Sodium [Moles/volume] in Serum or Plasma

4747

41733

2.74

86.56

21.4

14.1

139.66

mmol/l

0.01

4676

40577

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4313

36483

2.12

85.10

7.3

5.1

40.64

39.17

mmol/mol

13.96

4069

33839

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1409

8497

1.91

84.31

1.4

1.3

1.46

2.27

u/ml

1.59

470

2288

(3015235) Bicarbonate [Moles/volume] in Capillary blood

273

764

3.72

83.37

4.4

3.5

24.88

24.60

mmol/l

0.46

267

752

(3023103) Potassium [Moles/volume] in Serum or Plasma

4746

41886

2.68

82.73

21.6

14.2

3.96

3.97

mmol/l

0.55

4664

40646

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1512

9379

1.87

82.56

2.5

2.1

3.00

2.87

mg/l

1.24

1338

8029

(3000850) Epithelial cells [#/volume] in Urine

1329

7928

1.91

81.82

3.2

2.5

5.56

5.50

e6/l

0.06

1202

7064

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

947

5048

2.07

80.38

2.9

2.6

23.64

23.56

0.06

821

4339

(3040151) Glucose [Moles/volume] in Capillary blood

172

347

5.09

80.34

50.0

6.9

7.88

7.13

mmol/l

1.53

142

297

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1103

6212

1.99

80.31

1.4

1.2

19.63

32.65

iu/ml

6.37

305

2016

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4672

41102

2.46

78.94

19.2

12.5

20.49

24.75

mg/l

17.21

3985

31821

(40768797) Stomach Pathology biopsy report

919

4884

2.07

78.47

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

936

5009

2.06

78.42

1.4

1.3

486.95

520.15

titre

0.22

167

1037

(3009508) Creatinine [Moles/volume] in Urine

1760

11623

1.78

77.10

3.5

3.2

7.90

7.79

mmol/l

0.41

1527

9938

(3026782) Osmolality of Urine

1269

7585

1.89

76.95

3.4

2.8

555.83

556.66

mosm/kgh2o

0.04

1088

6472

(3044889) 12 lead EKG panel

3439

27400

1.77

76.68

4.3

3.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

274

841

3.38

72.58

4.3

3.0

24.91

27.33

mg/l

0.48

209

529

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1312

8052

1.84

72.54

1.8

1.7

0.88

1.27

mg/l

8.78

984

6134

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1018

5812

1.94

70.14

1.4

1.2

15.25

12.97

u/ml

0.18

419

2292

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1030

5919

1.92

69.53

3.1

3.5

0.82

mmol/l

1.17

946

5566

(3048689) Calprotectin [Mass/mass] in Stool

860

4674

2.01

68.17

2.2

2.4

115.22

138.56

ug/g

1.13

676

3745

(3028707) Methadone [Presence] in Urine by Screen method

236

700

3.49

65.91

3.0

2.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

860

4744

1.98

65.08

6.4

6.3

1.05

1.04

mmol/l

0.10

794

4432

(3026008) Bacteria identified in Urine by Culture

1611

10843

1.71

63.18

3.5

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

157

363

4.43

62.16

6.2

5.9

382.72

372.37

umol/l

0.34

143

305

(3021901) Oxygen saturation in Capillary blood

200

564

3.65

60.27

3.2

3.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1484

9930

1.69

58.60

2.9

2.6

3417.75

4762.32

umol/l

0.69

1311

8816

(3002385) Erythrocyte distribution width [Ratio]

4153

36044

1.78

57.05

22.7

15.2

14.61

14.77

0.53

4104

35359

(3020682) Albumin/Creatinine [Ratio] in Urine

1620

11182

1.65

56.34

4.2

3.8

9.98

9.76

mg/mmol

0.06

1112

7203

(3021589) Normoblasts [#/volume] in Blood

2351

17813

1.59

55.43

10.7

9.0

0.00

e9/l

1.47

1997

14523

(3013512) EKG study

1515

10339

1.66

54.78

4.5

3.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

230

754

3.15

54.59

1.2

1.3

420.00

543.60

mg/l

5.72

216

719

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

210

656

3.29

53.98

1.1

1.3

3.59

3.75

mmol/l

1.54

204

618

(3007164) IgA [Mass/volume] in Serum or Plasma

1178

7550

1.73

53.77

1.6

1.5

2.40

2.44

g/l

0.23

758

4680

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

286

1068

2.78

53.73

4.5

4.8

24.66

24.65

mmol/l

0.01

272

977

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4799

44069

2.29

50.61

21.6

14.4

80.35

77.56

umol/l

4.88

4799

44057

(3023368) Bacteria identified in Blood by Culture

1471

10149

1.63

50.05

4.7

4.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

456

2184

2.19

49.75

3.4

4.49

4.53

pmol/l

0.32

406

1945

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

202

652

3.18

49.19

1.3

1.4

3151.35

6497.49

e6/l

0.22

179

518

(3018677) aPTT in Platelet poor plasma by Coagulation assay

867

5225

1.79

48.51

1.9

2.2

29.69

30.02

0.95

839

5058

(40761511) CBC panel - Blood by Automated count

4734

43383

2.12

47.83

18.4

11.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

200

653

3.15

47.78

1.3

1.4

28.87

27.53

e6/l

0.02

165

494

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4802

44268

2.24

47.44

12.5

9.4

28.32

26.33

u/l

2.09

4701

42671

(3008152) Bicarbonate [Moles/volume] in Arterial blood

450

2187

2.16

47.25

6.4

6.8

24.84

24.36

mmol/l

1.84

433

2074

(3003396) Base excess in Arterial blood by calculation

709

4054

1.87

46.97

6.3

7.5

1.60

0.98

mmol/l

4.13

565

3187

(3015171) Extractable nuclear Ab [Units/volume] in Serum

321

1355

2.46

46.93

1.3

1.2

0.64

1.39

u/ml

1.10

130

(3025159) Blasts/100 leukocytes in Blood

549

2886

2.01

46.70

3.9

4.3

0.02

0.48

1.77

151

781

(3017181) Myelocytes/100 leukocytes in Blood

592

3204

1.96

46.30

3.9

4.3

0.82

0.96

0.67

194

1095

(3005322) IgE [Units/volume] in Serum or Plasma

454

2232

2.13

46.25

1.4

1.3

439.07

230.99

u/ml

0.45

424

2057

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1022

6532

1.70

46.23

2.7

3.2

2.44

2.45

mmol/l

2.10

903

5734

(3000570) Elastase.pancreatic [Mass/mass] in Stool

260

999

2.69

46.16

1.5

1.4

310.98

272.55

ug/g

2.06

159

596

(3021440) Promyelocytes/100 leukocytes in Blood

568

3038

1.98

45.96

3.9

4.3

0.09

0.11

0.15

170

933

(3012516) Albumin [Mass/volume] in Urine

1500

10582

1.59

45.72

3.6

3.2

515.11

357.91

mg/l

0.57

1029

6800

(4200892) Spirometry reversibility

478

2425

2.07

44.77

1.4

—

(3016502) Oxygen saturation in Arterial blood

648

3674

1.87

43.90

6.5

7.9

94.15

95.81

4.60

627

3537

(44816559) Phosphatidylethanol [Mass/volume] in Blood

203

707

2.95

43.34

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

208

737

2.90

43.04

2.0

2.2

136.15

129.18

g/l

3.46

175

534

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

961

6162

1.69

42.56

3.3

2.9

2.92

2.24

e6/l

1.17

595

3363

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

476

2458

2.03

42.40

2.4

26.93

22.56

au/ml

0.24

218

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4305

38611

1.70

42.15

17.3

11.8

83.77

83.43

ml/min/173m2

0.41

3478

31554

(3000034) Microalbumin [Mass/volume] in Urine

130

349

3.80

42.11

3.2

71.35

31.59

mg/l

0.87

265

(3011288) Drugs identified in Urine by Screen method

280

1166

2.48

42.10

3.2

2.7

—

(3022145) Colonoscopy Study observation

707

4185

1.80

41.51

1.3

1.4

—

(3019060) Gas panel - Arterial blood

436

2207

2.07

40.97

4.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

729

4407

1.76

39.72

1.9

1.7

—

(3000494) Fungus identified in Specimen by Culture

724

4378

1.76

39.38

1.5

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

484

2584

1.96

39.12

1.8

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4511

41187

1.76

38.81

5.5

4.3

2.71

2.79

mmol/l

8.72

4258

38169

(1616796) Gas panel - Central venous blood

198

725

2.80

38.55

3.6

3.7

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

228

4.36

38.55

11.4

12.6

0.61

0.62

mmol/l

0.17

210

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

680

4074

1.77

38.11

6.5

7.5

5.22

5.07

kpa

3.32

648

3884

(3027801) Oxygen [Partial pressure] in Arterial blood

679

4072

1.77

37.92

6.5

7.4

11.31

12.64

kpa

9.14

647

3885

(1001926) Buprenorphine [Presence] in Urine by Screen method

302

1367

2.28

37.60

3.0

2.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4282

38690

1.63

36.71

4.5

3.6

1.39

1.26

mmol/l

23.66

4027

35667

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1030

6950

1.60

36.63

4.4

3.4

250.05

555.49

ng/l

1.72

732

5393

(40758558) Short blood count panel - Blood

1393

10067

1.53

36.54

6.6

7.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

553

3151

1.85

36.54

2.7

1.9

12.13

13.03

nmol/l

1.84

498

2819

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

160

4.93

35.80

1.1

1.87

7.66

nmol/l

1.34

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4409

40200

1.67

35.65

5.0

3.9

1.38

1.46

mmol/l

10.66

4158

37294

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4434

40489

1.68

35.62

5.1

4.0

4.55

4.69

mmol/l

15.17

4198

37733

(3030467) Casts [#/volume] in Urine by Automated count

1457

10683

1.51

35.49

3.6

3.0

0.33

0.42

e6/l

1.50

1143

8024

(3025941) Bacteria identified in Stool by Culture

408

2145

1.98

34.35

1.3

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

5.94

33.79

1.8

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

102

5.94

33.79

1.8

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1363

9952

1.50

33.52

1.8

1.6

1.47

1.34

mmol/l

4.62

1185

8488

(3002173) Hemoglobin [Mass/volume] in Arterial blood

577

3415

1.78

33.49

6.9

8.2

125.44

121.17

g/l

4.93

566

3317

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

197

774

2.61

33.43

2.4

1.8

190.17

213.76

pmol/l

2.25

187

723

(3027945) Reticulocytes/100 erythrocytes in Blood

671

4159

1.71

33.03

3.0

2.6

1.73

1.74

0.05

610

3709

(36304419) Bacteria [Presence] in Urine

1412

10415

1.49

32.93

3.5

3.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

216

894

2.48

32.88

2.6

2.3

80.44

90.02

ug/min

0.13

147

544

(3021387) Prolactin [Units/volume] in Serum or Plasma

304

1457

2.15

32.85

1.7

1.6

345.31

304.10

mu/l

0.83

276

1308

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

461

2564

1.88

32.75

4.3

4.1

95.51

90.74

ng/l

0.51

401

2248

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

417

2251

1.93

32.45

1.3

70.41

55.86

au/ml

0.39

142

(3044242) Glucose [Moles/volume] in Arterial blood

175

4.51

32.16

1.8

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

304

1474

2.13

31.88

1.8

1.6

2.88

3.63

mg/l

1.27

268

1005

(3016879) Cocaine [Presence] in Urine

330

1658

2.06

31.49

2.8

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

492

2837

1.81

31.08

2.4

2.8

10.15

10.55

g/l

1.48

448

2605

(3020779) Urea [Moles/volume] in Serum or Plasma

570

3432

1.74

31.05

8.5

7.5

9.95

9.77

mmol/l

0.22

543

3285

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

137

4.94

30.89

2.5

2.2

—

(3044290) Cell count panel - Cerebral spinal fluid

163

614

2.71

30.10

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

499

2920

1.78

29.97

3.4

4.1

0.54

0.70

0.79

148

944

(3022689) Creatine [Moles/volume] in Urine

118

5.22

29.96

1.3

1.5

—

(3019977) pH of Arterial blood

193

4.14

29.22

1.9

2.8

7.39

7.43

0.45

(3013139) Helicobacter pylori Ag [Presence] in Stool

432

2451

1.83

28.71

1.2

—

(3027008) Opiates [Presence] in Urine

343

1806

1.96

28.66

2.8

2.0

—

(3028300) Cannabinoids [Presence] in Urine

343

1809

1.96

28.52

2.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

340

1789

1.96

28.47

2.8

2.0

—

(3042936) Bacteria identified in Isolate by Culture

808

5446

1.57

28.11

2.2

2.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

243

3.67

27.46

1.9

2.3

19.99

18.78

nmol/l

0.49

229

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

838

5739

1.55

27.08

2.0

1.8

—

(3027944) Amphetamines [Presence] in Urine

334

1777

1.94

27.06

2.8

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

556

3456

1.68

26.79

4.5

3.9

5.98

5.79

kpa

4.13

531

3354

(3018405) Lactate [Moles/volume] in Arterial blood

255

1242

2.11

26.41

3.3

4.1

1.40

mmol/l

0.01

248

1221

(3010421) pH of Blood

196

862

2.32

26.09

4.8

4.0

7.42

0.12

169

782

(3003327) Ova and parasites identified in Stool by Light microscopy

251

1222

2.11

26.02

2.0

1.8

—

(3012544) pH of Venous blood

566

3579

1.65

25.47

4.5

3.9

7.40

7.38

—

(3024354) Oxygen [Partial pressure] in Venous blood

467

2812

1.73

25.24

3.9

3.2

4.80

4.61

kpa

0.90

445

2722

(3009214) Lutropin [Units/volume] in Serum or Plasma

232

1111

2.14

25.11

1.4

9.13

10.18

u/l

0.64

185

898

(3045424) Erythrocytes [Presence] in Urine

150

594

2.57

25.10

1.6

1.5

—

(3002032) Base excess in Venous blood by calculation

547

3443

1.66

25.04

4.6

3.9

2.21

1.76

mmol/l

2.16

468

2855

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

9.14

24.72

2.4

2.6

25.18

25.50

umol/l

0.03

(40768804) Tissue Pathology biopsy report

1963

16008

1.37

24.25

2.2

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

375

2152

1.80

23.92

1.8

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

360

2047

1.82

23.67

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

103

345

3.03

23.67

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

434

2607

1.73

23.63

1.3

1.2

77.94

161.69

iu/ml

6.68

162

953

(3044640) Blood type and Crossmatch panel - Blood

1590

12580

1.38

23.55

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1024

7500

1.46

23.53

1.7

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

326

1805

1.86

23.35

1.2

1.1

50.00

173.37

titre

2.83

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2269

19009

1.35

23.17

2.7

2.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

248

3.39

23.04

1.2

1.0

247.85

279.77

mg/l

0.70

215

(3012501) Base excess in Blood by calculation

168

731

2.34

22.95

5.0

4.1

2.52

2.66

mmol/l

0.23

122

476

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

260

3.31

22.74

1.2

1.1

40.65

45.21

mg/l

0.27

214

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.21

22.45

1.9

2.2

14.52

16.95

umol/l

0.59

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3109

27366

1.34

22.40

3.4

3.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

171

763

2.28

22.05

2.7

2.9

32.29

35.00

umol/l

0.69

157

689

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

285

1542

1.90

21.93

2.4

1.8

40.89

39.45

u/l

0.58

260

1368

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

462

2883

1.66

21.77

4.2

3.9

1.22

mmol/l

0.02

406

2515

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

578

3811

1.58

21.76

3.7

3.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

592

3938

1.57

21.44

1.9

1.7

—

(3036180) Methadone [Presence] in Urine

184

3.68

21.15

2.7

2.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

301

1684

1.84

20.85

4.4

3.4

25.45

25.00

mmol/l

1.54

286

1625

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

200

975

2.09

20.69

1.3

1.2

18.37

31.99

u/ml

0.38

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

266

1435

1.90

20.65

2.1

1.9

1.32

2.92

ug/l

2.06

236

1267

(3009542) Hematocrit [Volume Fraction] of Blood

4892

46908

1.84

20.62

28.0

18.5

40.46

40.54

0.18

4571

44049

(3007461) Platelets [#/volume] in Blood

4895

46953

1.85

20.50

28.2

18.4

250.45

250.05

e9/l

0.16

4819

45658

(3023323) Follitropin [Units/volume] in Serum or Plasma

315

1806

1.79

20.13

1.4

1.3

22.93

27.51

iu/l

1.60

259

1538

(3010813) Leukocytes [#/volume] in Blood

4896

46992

1.84

20.07

28.2

18.4

6.89

6.70

e9/l

4.81

4811

45549

(3035941) MCH [Entitic mass]

4895

46983

1.83

20.02

28.0

18.3

30.27

30.31

0.92

4854

46301

(3028026) IgM [Mass/volume] in Serum or Plasma

370

2225

1.71

20.01

1.9

2.0

1.16

1.40

g/l

1.97

338

2034

(3024731) MCV [Entitic volume]

4895

46985

1.83

19.99

28.1

18.3

90.71

90.84

1.34

4854

46303

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

588

3965

1.55

19.98

2.0

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

4895

46992

1.83

19.87

28.2

18.3

4.54

4.52

e12/l

2.35

4811

45574

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

222

3.32

19.75

1.3

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

4895

47003

1.82

19.70

28.3

18.4

136.65

136.20

g/l

1.39

4852

46318

(40767503) Oxygen content in Capillary blood by calculation

155

697

2.26

19.65

2.8

2.5

17.21

16.10

2.53

344

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

642

4432

1.51

19.54

2.7

2.9

6.33

8.81

umol/l

3.95

532

3889

(3004588) Protein electrophoresis panel - Serum or Plasma

387

2371

1.68

19.53

2.0

2.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

190

3.51

19.45

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

459

2943

1.61

19.36

2.2

2.7

66.37

66.39

g/l

0.02

411

2692

(3011397) Hemoglobin [Presence] in Urine by Test strip

1162

8979

1.38

19.17

4.0

3.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

121

493

2.49

19.16

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

364

2208

1.70

19.06

3.8

3.2

130.50

128.81

g/l

0.79

350

2157

(1761868) Lipid panel - Serum or Plasma

1814

15009

1.32

18.99

3.4

2.6

—

(3023410) Appearance of Cerebral spinal fluid

297

2.93

18.80

1.5

—

(3022621) pH of Urine by Test strip

403

2521

1.65

18.76

3.1

2.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

240

3.16

18.70

1.1

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

158

734

2.19

18.53

1.3

1.2

23.16

35.82

u/ml

0.83

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

445

2864

1.61

18.46

3.0

2.7

182.36

206.52

ng/l

0.40

389

2601

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

279

1590

1.80

18.19

5.0

3.9

51.98

47.62

2.11

274

1570

(3042517) Benzodiazepines panel - Urine

7.61

17.81

4.0

2.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

878

6547

1.41

17.74

3.0

2.7

1.27

1.10

e6/l

0.42

508

3725

(3035637) Corticotropin [Mass/volume] in Plasma

107

428

2.53

17.64

1.7

1.5

—

(36660697) Celiac disease serology panel - Serum

465

3057

1.57

17.61

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

136

607

2.27

17.59

2.1

1.9

5.38

5.01

mmol/24h

0.58

121

529

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

203

1058

1.96

17.49

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

257

1446

1.82

17.49

5.4

4.5

1.80

1.63

1.10

246

1341

(3014765) Yersinia sp identified in Stool by Organism specific culture

204

1066

1.95

17.45

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

110

449

2.48

17.39

2.8

2.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

181

908

2.03

17.38

1.3

3.29

6.37

u/ml

1.21

144

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

179

896

2.03

17.29

1.3

1.2

4.02

2.90

u/ml

0.21

(3014111) Lactate [Moles/volume] in Serum or Plasma

491

3295

1.54

16.96

6.5

7.2

1.41

1.33

mmol/l

0.73

473

3210

(42529406) Shigella sp [Presence] in Stool by Culture

203

1072

1.93

16.84

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

195

1019

1.95

16.69

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

201

1065

1.92

16.51

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1077

8415

1.35

16.19

2.1

1.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

447

2978

1.55

15.93

2.7

2.2

5.83

8.32

ug/l

2.82

371

2639

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

205

1117

1.87

15.48

1.9

1.6

1.20

1.16

g/l

1.47

193

1060

(3016018) Differential panel - Cerebral spinal fluid

330

2.63

15.48

1.3

—

(3047181) Lactate [Moles/volume] in Blood

204

1114

1.87

15.30

6.1

5.2

1.32

1.23

mmol/l

0.76

185

968

(3020891) Body temperature

241

1385

1.78

15.30

4.5

4.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

247

1430

1.76

15.29

5.5

4.6

0.86

0.89

0.81

237

1330

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1748

14712

1.28

15.20

5.0

4.8

2.28

3.14

ug/l

3.12

1592

13262

(3008898) HLA-B27 [Presence]

236

1353

1.78

15.11

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

198

1077

1.87

15.04

1.9

1.6

0.23

g/l

0.09

187

1020

(3033658) Prothrombin time (PT) actual/Normal

1225

9846

1.32

15.03

4.0

90.66

89.78

0.59

1184

9606

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

518

3629

1.48

14.49

2.9

2.5

57.40

49.50

u/l

0.10

439

3136

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

593

4284

1.43

14.10

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

244

2.81

13.96

1.3

1.1

—

(3000991) Gas panel - Venous blood

461

3181

1.49

13.90

7.9

8.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

195

1084

1.83

13.85

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

207

1176

1.79

13.69

2.8

2.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

260

1579

1.68

13.57

1.4

1.6

7.03

13.62

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

189

1048

1.83

13.54

1.1

2.33

6.55

u/ml

1.87

145

(1761482) Bacteria [#/volume] in Urine by Culture

178

969

1.87

13.52

4.4

3.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

127

616

2.09

13.44

3.2

3.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

150

775

1.96

13.34

1.8

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

649

4812

1.40

13.29

2.2

2.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

140

3.38

13.25

1.2

62.60

65.94

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

676

5050

1.39

13.24

1.8

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

228

1347

1.72

13.18

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

277

2.62

12.96

1.8

1.3

1.72

1.36

promille

1.32

215

(3023511) Choriogonadotropin [Units/volume] in Urine

156

827

1.91

12.87

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

707

5348

1.37

12.80

2.4

2.1

—

(44813793) Dust mix specific IgE antibody measurement

253

2.67

12.52

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

226

2.76

12.40

1.0

813.97

734.83

ng/l

0.52

150

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

250

2.66

12.27

1.5

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

228

2.74

12.21

1.0

38.81

45.81

ng/l

0.80

159

(3048929) Epstein Barr virus Ab [Presence] in Serum

224

1348

1.69

12.13

1.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

342

2.39

12.02

1.1

1.2

—

42.80

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.77

11.98

1.4

80.13

237.35

nmol/24h

1.12

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

226

2.72

11.85

1.0

311.60

335.52

ng/l

0.25

157

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

3.25

11.74

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

790

1.89

11.67

2.3

1.8

0.84

0.77

nmol/l

0.67

124

671

(3000492) Spirometry study

517

3771

1.41

11.59

1.5

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

153

837

1.85

11.50

1.2

1.3

253.06

258.55

u/ml

0.10

108

514

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

176

1006

1.78

11.46

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

110

540

2.06

11.34

1.3

58.56

66.58

mmol/l

1.32

426

(40761536) Microorganisms panel - Urine sediment

452

3231

1.44

11.33

4.5

3.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

150

822

1.85

11.22

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

205

1232

1.69

11.18

1.7

1.6

88.85

255.11

titre

1.31

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

202

2.74

10.89

3.3

2.6

226.82

197.99

u/l

0.82

202

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

280

1833

1.56

10.80

2.5

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1383

1.64

10.79

1.6

2.4

7.41

7.40

g/l

0.03

189

1265

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1383

1.64

10.79

1.6

2.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

283

1861

1.55

10.70

5.3

4.3

24.73

23.94

mmol/l

3.93

273

1827

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

4.72

10.70

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

169

975

1.76

10.68

2.1

1.9

10.11

11.22

mg/l

1.12

161

912

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

1381

1.63

10.62

1.6

2.4

3.80

3.70

g/l

0.40

188

1263

(3045414) Leukocytes [Presence] in Urine

265

1721

1.57

10.59

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.02

10.50

1.2

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

157

891

1.79

10.50

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

106

530

2.02

10.43

1.2

—

(3011985) Renin [Units/volume] in Plasma

423

2.15

10.42

1.6

1.5

59.37

54.64

mu/l

0.13

370

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

1295

1.65

10.40

1.7

2.5

2.86

3.00

g/l

1.15

176

1179

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

196

1188

1.68

10.37

2.0

2.4

717.85

618.09

ug/l

0.12

178

1122

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

184

1097

1.70

10.36

1.8

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

147

3.01

10.35

1.5

1.7

1.96

1.95

umol/l

0.03

136

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

148

2.99

10.24

1.6

2.55

7.28

nmol/l

0.80

119

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

134

731

1.86

10.21

1.4

1.2

1.35

5.47

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

254

1649

1.57

10.18

2.5

2.2

2095.42

5984.12

u/l

2.38

671

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

234

2.54

10.07

1.2

1.3

1.11

2.66

u/ml

0.64

124

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

487

3601

1.39

10.06

2.2

2.3

0.22

0.21

g/l

0.74

448

3341

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

344

2389

1.47

10.04

2.3

1.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

166

2.85

10.04

1.1

1.0

1.07

1.13

u/l

0.26

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

419

3021

1.42

10.02

2.4

2.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

153

875

1.77

9.99

1.4

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

248

2.48

9.90

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

297

2.34

9.88

1.1

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

169

2.80

9.72

1.3

1.05

1.07

nmol/l

0.06

134

(3049717) Cytology report of Urine Cyto stain

221

1405

1.60

9.70

2.7

2.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

192

2.67

9.68

1.2

1.5

6.58

6.70

u/l

0.03

167

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

3.01

9.67

1.0

1.1

—

(40761535) Cells panel - Urine sediment

416

3015

1.41

9.66

3.9

3.2

—

(3024263) Appearance of Synovial fluid

198

2.64

9.65

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

430

2.06

9.26

1.9

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

157

2.82

9.25

2.3

1.5

90.57

146.07

umol/l

0.83

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1189

1.63

9.15

1.9

2.5

0.57

0.98

g/l

1.53

153

1035

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1380

11832

1.23

9.15

5.1

4.1

21.90

21.76

0.12

614

5797

(3052851) Hemolysis interference index of Serum or Plasma

182

1124

1.64

9.01

2.4

3.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

573

4421

1.33

9.00

3.0

4.6

233.52

245.36

u/l

1.38

539

4198

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

180

1111

1.64

8.93

2.0

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

160

962

1.68

8.79

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

408

2.05

8.62

2.3

2.7

1.45

1.34

g/24h

0.11

206

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

278

1915

1.48

8.49

8.4

10.1

24.74

24.24

mmol/l

1.87

262

1856

(4062490) Immunoglobulin typing, IgG

357

2.12

8.49

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

177

1103

1.63

8.48

2.3

3.9

46.03

110.63

mg/l

0.68

135

906

(3004716) Salmonella sp identified in Stool by Organism specific culture

302

2119

1.45

8.39

1.3

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

175

1091

1.63

8.37

3.4

3.7

1.58

1.47

mg/l

0.80

164

1007

(40760888) Immunoglobulin light chains.free panel - Serum

141

832

1.71

8.32

2.4

4.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

2.60

8.32

3.6

3.3

—

(3037756) Immunofixation for Serum or Plasma

128

736

1.76

8.28

1.4

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

169

1048

1.63

8.26

1.5

2.3

0.01

0.04

g/l

1.25

144

966

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

408

2.03

8.26

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

176

1104

1.62

8.22

2.3

3.9

35.81

61.77

mg/l

1.26

133

910

(3017569) Oxygen content in Arterial blood

162

2.67

8.20

2.0

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.57

8.11

1.0

—

(3039000) Anion gap in Blood

132

771

1.73

8.09

7.5

6.1

10.89

11.38

mmol/l

1.11

123

678

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

137

809

1.71

8.07

1.4

1.5

97.64

119.42

u/ml

1.67

156

(3018572) Chloride [Moles/volume] in Blood

132

772

1.73

8.05

7.5

6.1

105.86

105.04

mmol/l

1.33

123

679

(3017732) Neutrophils [#/volume] in Blood

365

2670

1.39

8.05

3.8

2.9

4.74

5.17

e9/l

0.30

311

2197

(21494755) Public health laboratory ask at order entry panel

334

4561

0.71

8.04

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

396

2.01

7.82

1.4

1.3

—

nmol/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

285

2.19

7.70

1.8

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.43

7.65

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

285

2015

1.44

7.63

8.6

9.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

170

1080

1.59

7.56

2.3

3.8

1.36

3.33

ratio

0.88

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

301

2.14

7.51

1.8

2.1

13.38

15.17

0.77

292

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.23

7.51

1.6

1.3

145.35

147.47

nmol/l

0.02

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

186

1213

1.55

7.40

2.8

3.1

0.37

0.32

u/ml

0.63

662

(3028192) IgG subclass 2 [Mass/volume] in Serum

357

2.03

7.37

1.4

2.75

2.93

g/l

0.43

257

(3023520) Reticulocytes [#/volume] in Blood

403

3042

1.35

7.33

2.6

71.53

67.98

e9/l

1.09

316

2288

(40768443) Skin Pathology biopsy report

230

1581

1.48

7.15

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

224

2.29

7.08

1.1

6.79

9.07

iu/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

547

1.81

7.06

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

356

2.01

7.06

1.4

0.38

0.41

g/l

0.25

255

(3008295) Osmolality of Serum or Plasma

336

2.04

7.04

1.6

1.4

290.43

279.83

mosm/kgh2o

3.17

265

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

140

2.65

7.04

1.6

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

357

2.00

7.01

1.4

6.36

6.81

g/l

0.75

255

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.97

6.98

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

457

1.87

6.91

1.4

1.3

65.23

31.34

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

289

2087

1.41

6.90

1.9

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1300

1.51

6.84

1.7

2.4

9.79

10.21

g/l

0.84

158

1173

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

197

2.35

6.78

1.3

1.2

4.61

5.16

umol/l

0.37

188

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

314

2.05

6.77

1.5

1.4

30.54

29.28

0.10

197

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

216

2.28

6.77

2.8

39222.45

41510.63

ug/l

0.43

216

(3002256) Pathology report gross observation

649

5280

1.26

6.76

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

398

1.92

6.70

1.4

352.50

301.17

pmol/l

0.47

338

(3030905) Polymorphonuclear cells [#/volume] in Blood

120

722

1.68

6.67

3.1

3.5

4.22

3.97

e9/l

0.65

120

722

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

123

746

1.66

6.64

3.7

58.27

57.29

0.38

123

746

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

105

2.87

6.62

1.9

1.7

68.99

131.71

au/ml

—

(3019225) pH of Specimen

448

3492

1.31

6.54

5.2

4.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.83

6.50

1.7

2.47

1.92

mg/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

100

577

1.75

6.48

1.3

—

(3037121) Protein [Mass/volume] in Urine

194

1316

1.49

6.47

3.5

3.4

0.27

0.36

g/l

0.98

599

(3004809) Band form neutrophils/100 leukocytes in Blood

106

625

1.71

6.37

3.1

3.6

1.52

1.65

0.14

547

(3024980) IgG subclass 4 [Mass/volume] in Serum

104

611

1.72

6.33

1.4

1.7

0.61

0.82

g/l

1.64

480

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

537

1.76

6.31

1.4

18.81

26.07

u/l

1.80

461

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

105

620

1.71

6.28

1.1

104.95

15729.74

iu/ml

0.53

149

(3008757) Leukocyte morphology finding [Identifier] in Blood

379

1.91

6.28

3.3

4.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

111

666

1.68

6.26

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.94

6.25

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

409

1.87

6.20

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

561

4532

1.27

6.20

7.4

6.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

219

2.20

6.14

1.4

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

240

1714

1.42

6.14

1.5

1.8

1.52

1.51

g/l

0.02

201

1484

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

139

2.53

6.09

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

220

2.19

6.08

1.4

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

12.52

6.07

1.5

382.14

590.88

nmol/l

—

(3003338) MCHC [Mass/volume]

3822

36545

1.18

6.01

24.0

15.9

332.97

332.96

g/l

0.02

3801

36248

(3020717) Zinc [Moles/volume] in Serum or Plasma

183

2.31

6.00

1.4

25.06

26.43

umol/l

0.09

174

(3024928) Oxygen saturation in Venous blood

127

804

1.59

5.83

3.4

3.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

103

619

1.68

5.81

1.6

1.5

0.39

0.37

nmol/l

0.08

499

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

137

2.49

5.76

1.9

2.1

8.89

9.96

mg/l

0.51

117

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

279

2.02

5.74

2.0

1.9

1.19

2.02

u/field

1.13

107

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

103

621

1.67

5.74

1.1

15.88

14.87

au/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.54

5.59

1.1

0.57

0.69

umol/24h

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

161

1086

1.50

5.57

1.5

2.2

38.03

37.52

g/l

0.50

126

967

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.06

5.48

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

584

1.67

5.45

1.4

—

(3004451) EKG impression Narrative

160

2.32

5.41

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

387

1.82

5.31

1.6

1.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

150

2.34

5.23

2.1

2.5

12.00

9.64

0.53

140

(3027456) Digoxin [Moles/volume] in Serum or Plasma

599

1.65

5.22

3.2

3.0

0.79

0.82

nmol/l

0.34

446

(3032057) Clostridioides difficile [Presence] in Stool

3.05

5.21

2.2

2.1

—

(3011412) CD3 cells [#/volume] in Blood

376

1.82

5.16

2.0

2.6

1.45

1.11

e9/l

1.40

334

(3000475) Leukocytes [#/volume] in Synovial fluid

131

861

1.54

5.15

1.6

12890.80

12670.33

e6/l

0.02

101

614

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

129

846

1.54

5.13

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

237

2.03

5.09

1.0

—

(3044927) Protein electrophoresis panel - Urine

328

1.87

5.06

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.28

5.02

2.3

1.6

140.07

151.19

ng/l

0.12

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

160

2.26

4.97

4.3

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

154

2.28

4.94

2.3

4.8

76.29

63.45

mg/l

0.58

114

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

148

2.31

4.92

1.7

2.3

26.56

28.80

0.49

139

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

204

2778

0.72

4.88

1.4

—

(3036489) Thrombin time

188

1344

1.41

4.86

1.8

2.3

20.82

21.76

1.21

159

1169

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

128

849

1.52

4.85

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

407

1.75

4.81

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.83

4.81

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

408

1.75

4.77

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

326

4134

0.77

4.74

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

403

1.75

4.68

2.6

2.0

33.10

21.65

mg/l

0.67

100

(3042631) Mycobacterium sp identified in Specimen

479

1.68

4.65

2.9

2.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

331

1.82

4.63

3.4

3.9

—

(4146454) Self-monitoring of blood glucose

325

1.82

4.58

2.7

2.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

831

1.50

4.50

5.0

5.7

432.33

3401.71

iu/ml

0.83

129

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.86

4.48

1.1

—

(3006270) Folate [Moles/volume] in Blood

313

1.83

4.47

1.1

413.46

378.73

nmol/l

0.57

266

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.53

4.45

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

128

867

1.49

4.42

1.7

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

122

820

1.50

4.38

1.6

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

352

1.77

4.37

2.5

5.2

62.22

59.30

u/ml

0.02

102

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

550

1.61

4.36

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

450

1.68

4.35

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

504

1.64

4.34

1.6

2.0

1760.00

1284.85

titre

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

4.34

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

6.26

4.29

1.1

8.81

8.14

mmol/l

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

477

1.64

4.22

1.5

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

478

1.64

4.19

1.5

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

140

2.22

4.17

1.3

1.2

144.58

162.88

mmol/24h

0.65

140

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

488

1.63

4.12

1.4

1.6

—

(3001729) Color of Synovial fluid

4.34

4.12

1.1

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

136

947

1.45

4.11

1.5

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

708

6110

1.18

4.08

1.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

399

1.69

4.03

1.7

1.5

61.96

58.61

0.29

259

(3024891) Influenza virus A+B Ag [Presence] in Specimen

147

1043

1.42

4.03

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

476

1.63

4.01

1.5

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

618

1.55

4.00

1.8

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

479

1.62

3.92

1.4

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

882

1.45

3.91

1.6

1.9

2.70

4.84

iu/l

3.72

331

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

550

1.57

3.91

1.1

2.90

3.53

u/ml

0.20

273

(3020491) Glucose [Moles/volume] in Blood

269

1.83

3.90

2.0

6.85

6.51

mmol/l

0.51

196

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

631

1.53

3.87

1.6

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

2.34

3.82

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

112

763

1.48

3.82

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

112

763

1.48

3.82

1.4

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

437

1.63

3.79

3.4

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

317

1.74

3.74

1.3

220746.32

60714.21

e6/l

0.60

221

(3051593) INR in Capillary blood by Coagulation assay

102

2.36

3.73

1.6

12.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

479

1.60

3.69

1.5

—

(3017509) Phencyclidine [Presence] in Urine

3.60

3.69

1.3

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

117

810

1.45

3.69

1.2

1.1

1.36

2.45

u/ml

1.18

398

(3041806) Other cells [#/volume] in Blood by Manual count

197

1.94

3.61

2.2

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.75

3.58

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

181

1358

1.34

3.58

2.2

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

138

991

1.40

3.57

1.5

2.3

0.00

g/l

0.50

115

911

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

117

2.23

3.57

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

149

1088

1.38

3.50

1.1

1.3

71.25

193.26

titre

1.23

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

136

979

1.40

3.48

1.5

2.3

0.00

g/l

-0.00

115

909

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

193

1.92

3.47

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

2.61

3.46

1.2

1.3

—

(3036603) Volume of Urine

258

1.79

3.45

1.4

1.7

1864.07

1916.03

0.16

252

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.55

3.42

2.0

34.30

46.45

umol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

289

1.74

3.40

1.1

1.0

275.61

288.10

mg/l

0.61

262

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

790

6980

1.16

3.38

1.8

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

120

2.17

3.37

1.1

1.2

93.77

87.36

0.52

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.01

3.36

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

636

1.49

3.36

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

168

1260

1.34

3.35

1.6

1.5

2.05

6.95

iu/ml

0.48

277

(3038026) Centromere Ab [Units/volume] in Serum

262

1.76

3.30

1.3

1.2

—

66.87

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.93

3.28

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

3.93

3.28

1.1

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

194

1492

1.31

3.27

2.3

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

122

2.14

3.25

2.0

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

2.14

3.25

1.1

94.62

90.59

0.28

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

249

1.77

3.23

1.2

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

426

1.58

3.19

1.7

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

426

1.58

3.19

1.7

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.17

3.19

1.1

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

491

1.54

3.15

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

181

2341

0.76

3.15

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

124

2.10

3.13

1.3

1.2

0.31

0.30

g/l

0.37

(3000012) Reticulocyte production index

532

1.51

3.13

1.7

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

104

731

1.43

3.09

1.1

4.34

5.91

u/ml

0.48

384

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

152

1.98

3.09

2.7

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

283

1.70

3.07

1.2

1.5

12.37

12.68

umol/l

0.10

265

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

471

1.54

3.05

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

471

1.54

3.05

1.8

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

131

961

1.37

3.04

1.4

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

395

3326

1.20

3.04

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

254

1.74

3.04

2.0

2.9

0.26

0.20

e9/l

0.84

218

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

361

1.61

3.03

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

618

1.46

3.02

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

618

1.46

3.02

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

126

2.07

3.02

1.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

2.21

2.99

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

263

1.72

2.98

1.9

2.9

782.32

461.71

e6/l

0.90

220

(3001964) Herpes simplex virus Ag [Presence] in Specimen

107

2.15

2.96

2.0

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

507

1.51

2.95

1.1

1.56

1.53

g/l

0.21

457

(3020874) Milk IgE Ab [Units/volume] in Serum

257

1.72

2.93

1.0

1.1

17.27

3.14

u/ml

0.43

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

598

1.46

2.92

1.2

21.86

41.77

u/l

1.86

517

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.43

2.87

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

158

1.90

2.79

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.55

2.78

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.55

2.78

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.55

2.78

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.08

2.76

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.08

2.76

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

944

8556

1.13

2.75

2.9

0.75

0.77

ug/l

0.18

594

5634

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

475

1.50

2.74

5.0

6.6

10.29

11.68

mg/l

2.18

439

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

496

4304

1.17

2.72

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.50

2.69

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

112

2.06

2.66

1.9

2.4

207.86

170.68

e6/l

0.36

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

145

1107

1.32

2.64

2.0

2.7

187.80

191.40

0.16

135

1053

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

312

1.61

2.63

1.2

1.3

164.40

175.63

pmol/l

0.26

312

(3051651) Icteric interference index of Serum or Plasma

228

1.72

2.62

1.9

3.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.46

2.61

1.1

1.3

9.86

0.37

u/ml

0.47

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.67

2.59

1.7

1.2

23.40

14.33

nmol/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

163

1.85

2.57

2.2

2.9

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.06

2.56

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.23

2.51

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

328

0.46

2.50

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1138

0.71

2.50

1.3

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

217

1.71

2.47

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

705

1.38

2.45

1.1

1.32

1.17

u/ml

0.08

296

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

116

1.99

2.45

1.3

1.2

101.50

108.60

0.36

104

(3006442) Creatine [Moles/volume] in Serum or Plasma

241

1.66

2.43

1.4

1.5

81.45

81.90

umol/l

0.03

241

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

360

1.53

2.39

3.7

3.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

227

1.68

2.39

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

160

1258

1.28

2.38

1.3

1.4

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

6.25

2.37

1.2

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.82

2.34

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.09

2.32

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

544

1.42

2.31

1.6

1.5

—

(3017704) Immunofixation for Urine

192

1.72

2.29

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.94

2.28

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.94

2.28

1.4

3.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

414

1.48

2.26

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

547

1.41

2.25

1.2

1.3

4.89

3.80

u/ml

0.33

247

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.28

2.24

1.0

1.2

3.80

4.53

u/ml

0.06

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

913

0.70

2.20

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

190

1543

1.24

2.17

2.1

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.00

2.14

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

137

1.83

2.13

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

151

1198

1.27

2.12

2.0

2.8

3.73

3.62

g/l

0.38

141

1133

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.45

2.10

1.1

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

109

1.93

2.10

1.0

1.1

2.00

36.04

u/ml

0.54

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

221

1.63

2.08

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.91

2.07

4.3

4.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

390

1.47

2.06

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

686

1.35

2.04

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.00

2.04

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.08

2.01

1.1

2.10

1.45

umol/24h

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.63

2.00

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

2.82

2.00

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

170

1.71

1.99

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

170

1.71

1.99

1.5

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

157

1264

1.25

1.97

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.95

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

105

1.91

1.95

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.36

1.94

1.3

1.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.55

1.94

2.0

1.2

—

(40768446) Kidney Pathology biopsy report

164

1.71

1.94

1.7

1.6

—

(3007463) Buprenorphine [Presence] in Urine

3.75

1.93

19.0

5.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

676

1.34

1.92

1.1

2.43

1.79

u/ml

0.27

339

(3003740) Influenza virus B Ag [Presence] in Specimen

685

1.33

1.92

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

729

1.32

1.91

1.5

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

523

1.38

1.90

1.1

123.00

114.85

1.20

474

(3014271) Vancomycin [Susceptibility]

150

1.74

1.90

3.6

2.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.00

1.90

2.2

2.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.65

1.86

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.65

1.86

1.0

—

(3016750) Collection duration of Urine

213

1.60

1.85

2.5

2.1

525.56

487.12

min

1.46

164

(3019832) Treponema pallidum Ab [Presence] in Serum

518

4644

1.13

1.84

1.8

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.21

1.84

1.7

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.53

1.83

1.3

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

152

1.71

1.82

1.6

1.5

4.33

4.41

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

536

1.37

1.82

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

492

4403

1.13

1.81

4.9

4.1

31.18

32.47

2.02

376

2944

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

279

1.51

1.78

2.3

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

104

1328

0.78

1.78

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.17

1.77

24.3

11.1

5.00

5.99

mmol/l

0.87

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

358

3142

1.15

1.77

2.8

2.6

64.46

68.18

ml/min/173m2

1.00

179

1206

(3028308) Erythrocytes [#/volume] in Pleural fluid

429

1.40

1.76

1.5

1.4

85683.73

53476.11

e6/l

0.22

247

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

557

1.35

1.75

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.98

1.74

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

688

1.31

1.73

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

558

1.35

1.73

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

1.72

1.1

—

(3008607) Semen analysis panel

2.92

1.72

1.0

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.92

1.72

1.9

2.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1038

0.76

1.69

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

683

1.31

1.68

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

259

1.51

1.67

1.0

1.1

4.77

2.82

u/ml

0.19

(3044941) Cell count panel - Synovial fluid

579

1.33

1.67

1.6

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.50

1.66

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.16

1.66

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

260

1.50

1.65

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

252

1.51

1.65

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1011

0.76

1.65

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

231

1974

1.18

1.63

4.5

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

148

1216

1.22

1.60

1.8

2.4

95.99

90.46

2.75

139

1167

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1227

0.79

1.57

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

590

0.69

1.57

2.7

3.6

24.88

29.13

u/ml

0.27

573

(4034850) Laboratory test

155

1283

1.21

1.57

8.8

8.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1036

0.77

1.56

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

137

1.68

1.55

5.1

4.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.89

1.54

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.93

1.54

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

224

1.52

1.53

1.0

1.1

0.79

5.09

u/ml

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.43

1.53

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

564

1.32

1.50

1.2

9.29

4.29

u/ml

0.62

181

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.95

1.48

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

470

1.34

1.48

1.5

2287.15

2195.75

e6/l

0.05

329

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1015

0.77

1.47

1.5

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.88

1.44

1.3

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.31

1.43

1.1

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.43

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

380

1.37

1.40

1.3

1.4

5.82

6.32

mmol/l

0.64

354

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1229

0.80

1.39

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1228

0.80

1.39

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.94

1.38

4.3

5.9

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.94

1.38

1.0

1.1

0.73

6.05

u/ml

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

119

1.68

1.37

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1224

0.81

1.35

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

323

1.40

1.35

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

323

1.40

1.35

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

323

1.40

1.35

1.8

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.14

1.33

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

113

1.68

1.31

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

378

1.35

1.28

2.0

3.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.29

1.26

2.1

2.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

178

1.52

1.25

1.7

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

286

1.40

1.25

1.9

1.5

—

(3004775) Volume in Urine collected for unspecified duration

312

1.38

1.23

2.7

2.2

661.25

619.91

0.35

206

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

205

1785

1.15

1.21

2.6

3.4

64.17

53.64

u/ml

0.17

199

1723

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

156

1.54

1.19

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

648

1.25

1.19

1.7

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.75

1.18

1.3

2.6

106.20

115.37

ng/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

129

1529

0.84

1.18

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

157

1.53

1.17

1.0

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.93

1.17

1.1

1.3

127.38

132.80

ng/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

198

1.47

1.16

1.1

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

1.16

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.15

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

174

1.50

1.15

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.81

1.15

1.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1011

9588

1.07

1.10

2.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.38

1.09

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

104

1.64

1.09

1.3

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.82

1.08

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

355

1.33

1.08

2.0

2.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.19

1.08

1.1

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

532

1.26

1.07

1.5

30.91

33.32

g/l

0.90

485

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.87

1.07

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

649

1.24

1.06

1.4

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

163

1415

1.16

1.04

1.5

1.3

222.63

225.16

miu/ml

0.03

682

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.96

1.03

1.7

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

1.45

1.02

1.7

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

334

0.69

1.01

5.8

3.9

26.19

42.88

u/ml

1.38

334

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

238

0.63

1.00

7.3

6.3

33.83

12602.75

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

248

1.37

0.99

1.4

1.7

12.18

6.43

u/l

0.95

208

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

164

1.47

0.99

1.0

1.1

97.28

90.94

0.46

133

(3014133) Dog dander IgE Ab [Units/volume] in Serum

576

1.24

0.97

1.1

1.47

3.31

u/ml

2.23

271

(3000285) Sodium [Moles/volume] in Blood

1.80

0.96

1.2

1.1

—

(3014891) Appearance of Pleural fluid

1.85

0.96

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

532

1.24

0.95

1.1

3.36

4.27

u/ml

0.23

211

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

302

1.33

0.95

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.89

0.94

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

1.39

0.92

1.6

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.82

0.92

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.14

0.91

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.67

0.91

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

176

1.42

0.90

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

236

1.36

0.89

3.8

6.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.91

0.88

2.1

2.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

177

1.41

0.88

1.1

1652.09

1493.77

miu/ml

0.29

177

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.82

0.85

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

1.50

0.85

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.94

0.84

1.0

1.1

—

13.10

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.30

0.84

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

162

1.42

0.84

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

301

1.30

0.82

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

301

1.30

0.82

1.1

—

(3045788) Cell count panel - Pleural fluid

372

1.27

0.82

1.6

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

498

1.23

0.82

1.9

2.0

20.20

24.47

ug/l

0.34

491

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

215

1.35

0.80

1.1

1.2

1.06

1.04

ratio

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

114

1.49

0.79

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

0.79

2.7

2.0

0.33

0.67

u/field

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

386

1.25

0.75

2.6

2.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

2.08

0.74

1.2

1.1

—

17.50

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.64

0.73

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.00

0.72

1.8

2.9

2.33

3.37

mg/l

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.72

1.3

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

525

1.20

0.72

4.4

2.5

13.18

13.11

0.26

520

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

300

1.27

0.70

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

300

1.27

0.70

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

576

0.81

0.70

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

364

1.24

0.69

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

170

1.35

0.67

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

119

1.43

0.66

1.6

1.5

10.56

8.12

ug/l

1.63

119

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.79

0.66

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

108

952

1.14

0.64

1.3

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.72

0.64

1.0

6.40

18.41

u/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

505

1.19

0.64

2.3

2.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

281

0.75

0.63

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

479

1.19

0.62

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.63

0.62

1.4

1.1

—

(40757373) Influenza virus identified in Isolate

1.59

0.61

2.9

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.60

0.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.4

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

483

1.18

0.58

1.1

1.0

0.41

0.52

u/ml

0.11

130

(21494890) Protein electrophoresis panel - 24 hour Urine

402

1.20

0.56

1.9

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

195

1.28

0.54

27.4

25.1

112.21

113.73

ug/l

0.05

165

(3005570) Glucose [Moles/volume] in Urine

359

1.20

0.52

2.1

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

277

1.23

0.52

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

250

1.24

0.52

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.43

0.52

1.1

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.49

0.49

1.3

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

172

1.28

0.48

1.1

240.39

206.66

iu/ml

0.20

172

(3003694) ABO and Rh group [Type] in Blood

1269

12379

1.03

0.46

1.5

—

(3015183) Erythrocyte sedimentation rate

210

1.24

0.45

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

274

0.80

0.43

1.2

1.3

1.44

1.56

g/l

2.15

274

(21494434) Karyotype in Bone marrow

349

0.83

0.42

1.4

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

1.29

0.41

2.0

1.3

—

(3024932) HLA-DR beta [Type]

140

1.29

0.41

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3012441) Differential panel - Pleural fluid

426

1.15

0.40

1.6

1.5

—

(3011648) Oxygen content in Venous blood

305

1.18

0.40

3.2

2.5

11.14

11.01

0.09

305

(40768441) Liver Pathology biopsy report

304

0.82

0.40

1.3

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

150

1.27

0.40

2.0

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

150

1.27

0.40

2.0

2.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.40

0.0

1.3

—

4569.92

—

(3019174) dRVVT (LA screen)

1.43

0.39

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

372

1.16

0.38

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

364

1.16

0.37

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

152

1.25

0.37

2.0

2.4

—

(3024471) HLA-A [Type]

143

1.26

0.36

1.0

—

(3033799) Differential panel - Peritoneal fluid

135

0.74

0.36

2.4

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

245

0.82

0.35

1.5

1.6

—

(3002619) Bacteria identified in Specimen by Culture

0.64

0.35

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

254

1.18

0.35

4.3

2.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

108

1.30

0.35

23.1

6.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

245

1.18

0.35

3.0

2.9

41.30

40.01

0.15

128

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

153

1431

1.07

0.35

1.4

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.33

1.3

2.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

136

1.25

0.33

4.1

2.7

19.80

83.95

au/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

421

4060

1.04

0.32

3.3

4.4

28.97

23.86

ug/l

0.10

350

3327

(3014051) Protein [Presence] in Urine by Test strip

1040

0.92

0.32

2.9

2.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

0.81

0.32

1.1

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

327

0.86

0.31

1.4

1.5

0.87

0.94

g/l

0.87

327

(3044007) Cell count panel - Peritoneal fluid

119

1.26

0.31

2.3

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.71

0.30

1.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

841

1.08

0.29

2.8

3.9

146.49

836.73

u/ml

1.33

766

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

163

0.80

0.29

1.2

—

(3025130) Human papilloma virus identified in Specimen

526

1.10

0.28

1.4

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

216

0.83

0.28

1.2

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

153

1447

1.06

0.27

3.3

3.8

169.76

1875.79

u/ml

1.32

131

1239

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

196

1.17

0.27

1.9

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

1.17

0.27

1.9

2.1

—

(3006462) Nitrate [Presence] in Urine

178

1.18

0.26

4.9

3.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

141

1.21

0.26

1.1

1.0

3.73

7.95

u/ml

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

282

1.14

0.25

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

898

1.07

0.25

1.8

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.18

0.24

1.2

2.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.18

0.24

5.8

6.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

190

0.84

0.23

1.1

1.2

—

(3034426) Prothrombin time (PT)

136

0.81

0.23

1.0

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

608

0.92

0.22

1.3

3.05

4.29

ug/l

1.20

548

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.74

0.22

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.16

0.21

7.2

8.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.16

0.21

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.21

0.0

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

471

1.08

0.19

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

0.86

0.19

1.2

1.1

—

(3035880) pH of Pleural fluid

222

1.13

0.19

1.1

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.13

0.18

4.0

6.2

23.55

82.10

g/mol

—

(3045142) Bone marrow Pathology biopsy report

435

0.92

0.18

1.2

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.16

8.0

7.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

119

0.84

0.15

2.9

3.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

358

0.92

0.14

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

112

1.16

0.14

1.1

1.0

9.84

13.40

u/ml

—

(40768806) Pleura Pathology biopsy report

421

1.07

0.14

1.5

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

117

0.85

0.13

2.8

3.5

—

(40768793) Breast Pathology biopsy report

783

0.96

0.12

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

298

1.07

0.11

1.1

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

563

1.05

0.11

2.0

2.2

4.53

7.14

umol/l

1.41

421

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

299

1.07

0.10

1.3

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

4.6

1.5

—

(3006598) pH of Arterial cord blood

1.09

0.09

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.09

0.09

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.04

0.09

1.0

1.3

5090.00

37.37

u/l

—

(4281824) Cell count and differential, peritoneal fluid

389

1.05

0.09

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.13

0.09

27.0

6.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.78

0.08

1.2

1.3

—

147.58

—

(3001019) Free T4 and TSH panel - Serum or Plasma

224

2204

1.02

0.07

1.7

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.83

0.07

1.0

1.2

—

(3048879) Bone marrow aspiration report

105

0.86

0.06

1.2

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

129

1.09

0.05

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

344

0.96

0.05

1.3

1.6

7.56

7.75

mmol/l

0.20

334

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

110

0.91

0.05

1.3

41.68

447.08

ug/l

—

(3029075) Extractable nuclear Ab panel - Serum

110

1.09

0.05

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

191

0.94

0.04

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

191

0.94

0.04

1.2

1.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

268

1.05

0.04

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

130

1.08

0.04

9.0

1.3

—

(40768795) Lymph node Pathology biopsy report

393

0.97

0.04

1.2

—

(4035726) Immunohistochemistry procedure

346

3484

0.99

0.04

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

270

1.04

0.03

1.1

—

(3020650) Glucose [Presence] in Urine

102

1.08

0.03

1.3

—

(40768800) Prostate Pathology biopsy report

100

990

1.01

0.02

1.3

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

133

1.05

0.01

1.0

—

(40765096) Chromosome analysis panel by Banding

135

1.04

0.00

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

188

1.01

0.00

1.2

1.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

251

1.00

0.00

1.3

1.4

37.52

33.90

nmol/l

0.21

220

(3036071) Salmonella sp Ab [Titer] in Serum

149

1.01

0.00

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

150

1.00

0.00

1.6

1.9

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

2423.80

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.94

-0.00

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.3

—

35.31

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.44

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.95

-0.00

1.1

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

76.63

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.94

-0.00

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.90

-0.00

1.5

4.5

—

(3013637) Mi-2 Ab [Presence] in Serum

0.94

-0.00

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.94

-0.00

1.1

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

4.6

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SLEEPDISOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.334 [1.19, 1.49]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.532

During the follow-up period (1.1.1998 — 31.12.2019), 1071 out of 9820 females with G6_SLEEPDISOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_SLEEPDISOTH	1.354 [1.24, 1.48]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2424 out of 14274 males with G6_SLEEPDISOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_SLEEPDISOTH.

N-year risk	Females	Males
1	0.118%	0.226%
5	0.882%	1.469%
10	2.276%	3.58%
15	4.204%	6.951%
20	7.155%	11.548%

Relationships between endpoints

↥

Index endpoint: G6_SLEEPDISOTH – Other sleep disorders

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other sleep disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints